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ABSTRACT 
Understanding of regulation of reproduction at the level of the brain changed dramatically with 
the discovery of reproductive neuropeptides. To date there have been no studies to characterize the 
distribution of reproductive neuropeptides in the bovine hypothalamus at different stages of the estrus 
cycle or to determine the physiological effects of peripheral administration of Gonadotropin inhibiting 
hormone (GnIH) in intact female cattle and ovariohysterectomized bitches.  
The goal of the first study was to determine distribution and connectivity of kisspeptin, 
dynorphin, and GnIH in the hypothalami of sexually mature female cattle during the estrous cycle. To this 
end, hypothalami of female cattle were collected during periestrus and diestrus. The neuroanatomical 
distribution, synaptic connectivity, and response to different circulating progesterone concentrations 
suggest these neuropeptides play a pivotal role in the regulation of reproduction in cyclic cattle. 
Another goal was to test the hypothesis that IV administration of GnIH would decrease serum LH 
concentrations in post-pubertal heifers. Two studies were carried out to this end. The objective of the first 
study was to determine whether IV GnIH administration would decrease basal serum LH concentrations. 
The objective of the second study was to determine whether continuous IV administration of GnIH during 
the expected time of the LH surge had an effect on serum LH concentrations and ovulation. Results 
suggest that exogenous administration of GnIH decreases basal LH concentrations but is not able to 
suppress the surge release of LH or ovulation in post-pubertal heifers.  
Finally, the objective of the third study was to determine the effects of IV administration of GnIH 
on serum LH concentrations in ovariohysterectomized bitches as a potential alternative to surgical 
sterilization. Results suggest that IV administration of GnIH is not able to suppress serum LH 
concentrations in the ovariohysterectomized bitch. 
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In summary, expression of kisspeptin, dynorphin, and GnIH changes with progesterone 
concentrations in sexually mature female cattle. In addition, exogenous administration of GnIH affects 
basal plasma concentrations of LH but not LH surge characteristics in sexually mature female cattle. It 
also appears that exogenous administration of GnIH does not affect plasma LH concentrations in 
ovariohysterectomized adult bitches.  
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CHAPTER 1 
GENERAL INTRODUCTION
1 
 
“Ancient physicians and philosophers have called the disease hysteria from the name of the 
uterus, that organ given by nature to women so that they might conceive. I have examined many 
hysterical women, some stuporous, others with anxiety attacks: the disease manifests itself with different 
symptoms, but always refers to the uterus.” (Claudius Galen – Theories on Hysteria 2nd Century AD). 
From the philosophical wonderings of the Greek on anatomy of male and female reproductive 
organs to the current discoveries of molecular reproductive biology, procreation has been a human 
concern for centuries. Sexual reproduction is the evolutionary expensive mechanism of procreation and 
the reasons for its development are still a matter of discrepancy among evolutionists. Although in the past 
understanding procreation may have been a thing left to philosophers, in this day and age understanding 
the basics of reproductive physiology serves a more practical reason. By understanding the underlying 
mechanisms that regulate reproduction we can intervene in such processes to an advantage.  
The hypothalamus is involved in a variety of physiological functions including regulation of 
temperature, food and water intake, reproduction and sexual behavior, daily cycles and emotional 
responses. The hypothalamus is the central organ under which reproduction is governed, yet the 
understanding of how exactly the brain receives and imparts feedback to reproductive organs is still only 
marginally understood. Although it was suspected changing hormone levels were responsible for 
reproductive functions, until the development of radioimmunoassays by Yalow [1] and the isolation of 
GnRH by Schally [2] and Guillemin [3] in the 1970’s, much of the work was speculative at best.  
Eventually it became clear that although the hypothalamus regulates secretion of pituitary 
hormones, it does so by feedback from the ovaries and teste. The initial discoveries of a feedback 
mechanism between the brain and the sex organs came from studies done in cocks in which castration 
ensued fallen crests and underdeveloped male sexual characteristics and behavior as opposed to their 
intact counter parts or those which had received a homologous or heterologous testis [4]. Karsch later 
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described the influence of ovarian steroids on the secretion of GnRH [5]. GnRH neurons reside in the 
preoptic area (POA) of the hypothalamus and project to the median eminence (ME) where they release 
their peptide into the hypothalamic pituitary portal blood system [6]. With each pulse of GnRH there is a 
subsequent pulse in LH and FSH. Depending on the steroidal milieu, GnRH is secreted in more or less 
frequent pulses [7].  
Another neuropeptide discovered in the last 15 years is gonadotropin inhibiting hormone (GnIH). 
This hormone has been shown to decrease LH concentrations and is thought to have an important role in 
the negative regulation of reproduction [8]. GnIH was first discovered in birds and then its sequence was 
identified in mammals. GnIH is encoded by the RFRP-3 gene and exerts its action through a G-protein 
coupled receptor, GPR 147. Most of the studies carried out in mammals to describe the role of GnIH in 
reproduction have been in sheep. In ovariectomized sheep, peripheral injections of GnIH ablate estrogen 
benzoate-induced LH surge [9]. In intact sheep, GnIH decreases serum LH concentrations during the late 
follicular phase [9,10]. GnIH also appears to be involved in seasonality as GnIH mRNA expression is 
higher during the anestrus season in ewes [11]. Studies in other mammals have variable results. For 
example in rats GnIH was not found to be differentially expressed and in hamsters, GnIH appeared to be 
lower during the non-breeding season [12]. Peripheral injections of GnIH every 10 minutes decreased LH 
concentrations during the treatment period in male castrated calves [13]. Therefore it is clear that more 
studies to decipher the individual roles of GnIH in each species are necessary. To date, no experiments 
have been carried out in intact post-pubertal female cattle or dogs to identify effects of GnIH 
administration on LH concentrations. 
Because GnRH neurons do not possess the necessary steroid receptor ERα, until recently 
transmission of gonadal feedback on the hypothalamus remained a mystery. In 2003, kisspeptin 
(metastin) was discovered to have a major role in reproduction when a mutation in the kisspeptin receptor 
GPR54 led to a hypogonadotrophic hypogonadism phenotype in humans and mice [14,15]. Since its 
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discovery, many subsequent studies have demonstrated an essential role of kisspeptin in the positive and 
negative feedback mechanism of gonadal steroids onto GnRH neurons. Kisspeptin cells co-express other 
important neuropeptides also involved in the regulation of GnRH pulsatility. Neurokinin B (NKB) has 
been shown to have an autocrine positive effect on kisspeptin neurons and dynorphin (DYN) has been 
shown to mediate the negative effects of progesterone on GnRH secretion [16,17]. Because of the co-
expression of kisspeptin, NKB and DYN, these cells have been named KNDy neurons. These neurons are 
found in the arcuate nucleus (ARC) of the hypothalamus of mammals such as ewes and non-human 
primates. This grouping of cells has been implicated in the regulation of pulsatile secretion of GnRH. To 
this date there has been no description of the distribution of these peptides in the bovine hypothalamus at 
different stages of the estrous cycle. 
In both cattle and dogs uncovering the underlying mechanism of regulation of reproduction could 
have large practical implications. For example, development of GnIH analogues that negatively affect LH 
concentrations in cattle could be utilized as new drugs for estrus synchronization protocols. In dogs there 
has been an increasing push to find novel methods for contraception to help fight stray overpopulation. 
Determining what the underlying mechanisms are in the hypothalamic control of reproduction could lead 
in this species to permanent non-surgical sterilization methods for contraception. In the following section 
I will describe what we know about the hypothalamic control and characteristics of the estrous cycle in 
the two species relevant to this dissertation. I will also describe what is known to date about GnIH as the 
main focus of this dissertation together with other pertinent neuropeptides such as kisspeptin, DYN and 
NKB. 
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CHAPTER 2  
LITERATURE REVIEW
5 
 
2.1 HYPOTHALAMIC-PITUITARY ANATOMY 
The brain is divided into forebrain (Prosencephalon), midbrain (mesencephalon) and hindbrain 
(Rhombencephalon) [18]. The forebrain is sub-divided into the telencephalon and diencephalon. The 
thalamus and hypothalamus reside within the diencephalon. In the embryo, the diencephalon develops 
from the caudal portion of the prosencephalon and contains the thalamus, hypothalamus and a pair of 
lateral out pocketing (optic cups) from which the neural portion of the retina develops [18]. The 
hypothalamus makes up the ventral most portion of the diencephalon and extends from the cranial limit of 
the optic chiasm to the caudal limit of the mammillary bodies. Dorsally it is delineated by the third 
ventricle and the thalamus and ventrally by the pituitary [19]. The hypothalamus is composed of different 
sections called nuclei that harbor different neurons in charge of secreting hormones and neuropeptides 
essential to maintenance of homeostasis [20]. 
The hypothalamus can be divided into three major regions: 1) the rostral region constitutes the 
supraoptic region; 2) the middle or tuberal region where the infundibulum extends into the pituitary 
(median eminence); and 3) the posterior or mammillary region. Each of these sections is subdivided into 
smaller nuclei (Figure 1, a-c) [19]. Several of these nuclei are involved in the regulation of reproduction 
by harboring cells involved in the secretion of releasing factors affecting the pituitary gland. The effects 
of the hypothalamus on the pituitary have been known since the early 1950’s[21,22] but gonadotropin 
releasing hormone (GnRH) was characterized as the regulator of pituitary reproductive hormones in the 
early 1970’s[3,23]. The neurons that secrete GnRH are found in the preoptic area (POA) of the 
hypothalamus [24,25]. Other important neuropeptides secreted from the hypothalamus include kisspeptin 
(KP) and gonadotropin inhibiting hormone (GnIH). In sheep, humans and primates, kisspeptin secreting 
neurons are found in the arcuate nucleus (ARC) and POA of the hypothalamus [11,26-30]. In rodents, 
kisspeptin neurons are also found in ARC and the rostral periventricular area of the 3rd ventricle (RP3V). 
Kisspeptin neurons in the RP3V are clustered in the anteroventral periventricular nucleus (AVPV) and 
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extend in to the periventricular (PeV) area of the hypothalamus [31-33]. These differences in localization 
of KP neuron clusters are thought to correlate to differences in their roles throughout the estrus cycle (see 
KP cells, fibers and receptor localization below). In mammals, neurons that secrete GnIH are mainly 
located in the dorsomedial (DMN) and paraventricular nucleus (PVN) of the hypothalamus [9,11,34,35]. 
Some imunoreactive GnIH cells have been found in the PeVN of the male Rhesus macaque [34] and rats 
have been found to have a population of GnIH neurons in the ventromedial nucleus (VMN) [36]. 
Another important nuclei of the hypothalamus is the suprachiasmatic nucleus (SCN). It is in 
charge of regulating circadian rhythms by receiving input from photosensitive cells in the retina and other 
neurons within the hypothalamus [37]. It communicates with the pineal gland and sections of the preoptic 
area to modulate sleep, physical activity, hormone secretion and body temperature [38,39]. It is 
considered a central modulating nucleus that integrates external cues with internal biological functions 
such as seasonal reproduction [40]. 
The pituitary is an endocrine gland located in the depression at the base of the skull called the 
sella turcica, “Turkish saddle”. The pituitary can be divided into two major sections, the anterior pituitary 
(adenohypophysis) and posterior (neurohypophysis) pituitary [41]. These sections have distinct 
embryological origins that accounts for differences in function and relationship to the hypothalamus [42]. 
The anterior pituitary derives from the embryonic oral ectoderm (Rahke’s pouch) and receives 
hypothalamic releasing factors through the hypothalamic pituitary portal vein system. The posterior 
pituitary derives from the embryonic neuroectoderm (diencephalon) and is considered an extension of the 
hypothalamus. It releases hormones directly from the terminal endings of neurons located in the 
supraoptic and paraventricular nucleus of the hypothalamus [42]. Histologically the adenohypophysis is                         
further divided into pars distalis, pars tuberalis and pars intermedia [41]. The pars distalis is the largest 
section of the pituitary and contains five types of endocrine cells: somatotropes (secretes growth 
hormone, GH), lactotropes (secretes prolactin, PRL), gonadotropes (secretes follicle stimulating hormone 
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and luteinizing hormone, FSH, LH), corticotropes (secretes adrenocorticotropic hormone, ACTH) and 
thyrotropes (secretes thyroid stimulating hormone, TSH). The pars tuberalis contains gonadotropes and 
thyrotropes and the pars intermedia contains melanotropes (secretes melanocyte stimulating hormone, 
MSH). The pars intermedia is sometimes considered a third section of the pituitary and is separated from 
the pars distalis by the hypophyseal cleft [41]. 
2.2 HYPOTHALAMIC-PITUITARY PHYSIOLOGY 
The hypothalamus is involved in a variety of physiological functions including regulation of 
temperature, food and water intake, reproduction and sexual behavior, daily cycles and emotional 
responses. In this review I will concentrate on the hypothalamic control of the reproductive cycle in the 
species relevant to this dissertation. 
 2.2.1 Regulation of the reproductive cycle by the hypothalamic-pituitary-
gonadal axis (HPG axis) 
“In all species of domestic animals that have reached puberty there is a definite physiologic 
functional rhythm of the reproductive system, called the estrous cycle.” [43] 
Experimentation with endocrinology began with the observation of castrated roosters by German 
physiologist AA Berthold [4]. Berthold castrated several cocks and either placed the testis within the 
abdominal cavity of the same bird or transplanted it to a different animal and compared them to their 
castrated counterparts. “…So far as voice, sexual urge, belligerence and growth of combs and wattles are 
concerned, such birds remain true cockerels[…]. It follows that the results in question are determined by 
the productive function of the testis…” And so began the understanding of the effects of hormones on the 
brain. 
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Regulation of the reproductive cycle involves interaction between three main organs: the 
hypothalamus, the anterior pituitary and the gonads. In non-seasonal polyestrous animals, as progesterone 
drops after luteolysis, FSH and LH secretion increase in response to GnRH causing an increase in 
production of estradiol from the dominant follicle [44]. Estradiol in presence of low concentrations of 
progesterone, incurs in a positive feedback with the surge center of the hypothalamus inducing release of 
more frequent LH pulses (from 1 pulse every 4-6 hours to 1 pulse every hour) that in turn will surge and 
initiate the cascade of events leading to ovulation [45]. A surge in FSH is also observed at this time but 
not in the same magnitude as LH due to the secretion of inhibin and estradiol from the preovulatory 
dominant follicle that inhibit FSH secretion from the pituitary [42]. LH induces luteinization of theca and 
granulosa cells of the dominant follicle and the corpus luteum (CL) is formed after ovulation [44]. 
Secretion of progesterone over 2 ng/ml can be detected by day 4-5 after ovulation in most species [42] 
and earlier in some (e.g. dogs [46-48]). In the presence of high concentrations of progesterone, LH pulse 
frequency remains low [5] and estradiol rises periodically [49]. In polyestrous animals, after 
approximately 14 days under the influence of progesterone, the uterus starts to produce prostaglandin F2α 
(PGF2α) that causes an immediate decline in progesterone concentration [44,50,51]. After luteolysis the 
cycle re-initiates until pregnancy ensures. In monoestrous species, the increase in GnRH pulsatility and 
therefore FSH and LH secretion, starts after an extended anestrous period which can be seasonal (ewes, 
mares) or non-seasonal (dogs).  
The main regulator of this cyclic reproductive pattern is the hypothalamus. Next I will describe 
the particularities of the HPG axis for the two species pertinent to this dissertation, the cow and dog.  
Bovine estrus cycle 
Cattle cycle multiple times throughout the year (polyestrous, non-seasonal breeders) and are 
spontaneous mono-ovular species. Estrous cycle duration depends on the number of follicular waves for 
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that animal and can be anywhere between 17-25 days. The bovine estrous cycle can be divided into two 
defined periods: the follicular phase and the luteal phase [42]. The follicular phase (proestrus and estrus) 
extends from the regression of the CL to ovulation. The main structures present in the ovary are the 
growing follicles and the dominant hormone is estradiol. The luteal phase (metestrus and diestrus) 
extends from ovulation to regression of the CL. The main structure present in the ovary is the corpus 
luteum and the dominant hormone progesterone [42]. 
Puberty in cattle is generally defined as the first estrus accompanied by ovulation and followed by 
a normal lasting luteal phase [44]. Events that lead to the first estrous cycle involve an increase in 
frequency of GnRH pulses that will induce secretion of enough FSH and LH to initiate follicular growth, 
oocyte maturation and ovulation [52]. Follicle development occurs in waves in pre-pubertal heifers and 
mean serum concentrations of LH, estradiol and LH pulse frequency increases as timing of the first 
ovulation approaches [53,54b,55a]. After a short first cycle, heifers will continue with the same patterns 
associated with follicular growth, wave emergence and inter-wave intervals throughout their entire 
reproductive life [55]. Onset of puberty is influenced by several environmental factors such as breed, 
weight and season but in general cows reach puberty between 6 and 24 months [44] or when they have 
reached 40%-50% of their mature body weight [52]. 
The follicular phase in cattle is characterized by recruitment of a cohort of follicles from which 
one will emerge and become dominant [49]. This dominant follicle will suppress the remaining 
subordinate follicles and grow until ovulation occurs [56-60]. Once the dominant follicle has reached 
preovulatory size (>8 mm), females undergo estrus which lasts an average of 12 to 18 hours [44,52]. This 
phase is characterized by the expression of typical estrous behavior: cows stand to be mounted by bulls or 
other cows, cows in heat will come together in the so-called sexually active group, licking and smelling of 
the genitalia amongst other signs [61]. During this time the cow will allow mounting as ovulation 
becomes imminent. In general the first signs of estrus in the cow are associated with the beginning of the 
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preovulatory surge of LH and ovulation occurs within 24 to 30 hours after [44].  Development of a CL 
characterizes the luteal phase in which the female will no longer receive the male, progesterone becomes 
the main hormone in circulation and it extends from days 4 to 18 after ovulation [44]. The CL in the cow 
can first be detected at 2 days after ovulation and reaches its maximum size by day 9-10 after ovulation. 
Plasma progesterone concentrations exceed 2 ng/ml by day 4 or 5 and are maximum by days 8 to10 
[42,44]. Luteolysis in cattle is a mechanism regulated by oxytocin [62] and progesterone secreted by the 
CL and by PGF2α produced by the uterus. It is believed that exposure to high concentrations of 
progesterone and estradiol induces the development of oxytocin receptors on the endometrium. Oxytocin 
released from the CL and estradiol production from the dominant follicle, activate oxytocin receptors in 
the endometrium which in turn induces the endometrium to produce prostaglandins [63]. PGF2α is the 
main prostaglandin responsible for luteolysis in the cow and  reaches the CL through the utero-ovarian 
vascular countercurrent diffusion system to cause luteolysis [42,51]. Total or partial hysterectomy causes 
prolongation of the lifespan of the CL, indicating the important role of PGF produced by the endometrium 
in luteolysis [50,62]. 
Canine estrus cycle 
The bitch is a monoestrus, non-seasonal spontaneous ovulator with an anestrous period between 
cycles of 3-10 months [46,64]. Puberty occurs between 6 and 24 months depending on breed and adult 
body weight [65]. The canine estrous cycle is classically divided into four phases: proestrus, estrus, 
diestrus and anestrus [66,67].   
Proestrus lasts an average of 9 days (5-20 days) and is characterized by the male being attracted 
to the female without allowing copulation [46,67-69]. Physically, the female exhibits outward signs of 
estrogen exposure such as a swollen vulva, bloody vaginal discharge, urine marking and attractiveness to 
males. During this stage high estrogen levels promote edema of the reproductive tract with vulvar 
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swelling and increased vascularity of the endometrial epithelium leading to leaking of the capillary bed 
into the uterus and bloody vaginal discharge [67]. Estrogen also promotes epithelial cell proliferation with 
keratinization of the vaginal epithelium thought to be necessary for protection during copulation as well 
as edema of the vaginal mucosa creating a cobble stone appearance of the vaginal folds [47]. Serum 
estradiol increases throughout the duration of proestrus up to 40-120 pg/ml and will peak 1-3 days before 
the preovulatory LH peak [70,71]. Concurrent with increasing levels of estradiol, FSH and LH pulses are 
progressively suppressed due to the negative feedback of estradiol on the hypothalamus [46,48,67]. 
During proestrus, follicles grow up to 5-8 mm or larger and will continue to grow beyond the LH surge 
[72]. Mid-proestrus follicles in bitches show signs of luteinization like follicles in the late follicular phase 
in pigs [71-73]. 
Estrus lasts an average of 9 days (5-15 days) and is characterized by acceptance of the male by 
the female [67-69]. Physically, swelling of the vulva and bloody vaginal discharge decreases and 
receptivity to mounting and male seeking activities increase [67]. Estrous behavior changes can occur as 
early as 2 days before the LH peak to as late as 6 days after, or not at all [46]. Clinically, estrus lasts until 
vaginal crenulation and cornification of the vaginal mucosa decrease to pre-estrus levels with 
reappearance of non-cornified cells and neutrophils on cytological examination.  Changes in vaginal 
cytology mark the end of the fertile estrus period and lasts an average of 8 days (6-11 days) post LH-
surge after which estrous behavior may persist [47]. Endoscopically, the vaginal mucosa appears 
crenulated and reaches maximum crenulation on day 4-5 after the LH peak. Most of these changes are 
triggered by decrease in estrogen to progesterone ratio [47,68]. Estradiol continues to fall from peak 
values in late proestrus as progesterone rapidly increases, first up to values between 1-3 ng/ml usually 
during the LH peak, and then again immediately after the LH peak to values beyond 10-25 ng/ml by day 
10 [70]. 
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The LH surge is defined as the first 200% rise above the preceding mean concentrations [67]. The 
LH peak in the bitch reaches mean values of 8-15 ng/ml and occurs 1-3 days after the peak in estradiol 
[48,70]. The total length is 24-60 hrs and is accompanied by a peak in FSH and steady increase in serum 
progesterone concentrations [71]. What triggers the LH surge in these animals is evidenced in a study 
carried out in ovariectomized bitches [68,74]. In one group animals were administered increasing doses of 
estradiol benzoate for 66 hours to levels above normal peak values. In another group, animals were 
administered increasing doses of estradiol benzoate for 66 hours to levels above normal peak values and 
fitted with subcutaneous progesterone releasing devices the day estradiol injections stopped. During 
treatment with high doses of estradiol, LH remained basal. Animals in which estradiol benzoate was 
discontinued with no further treatment, LH concentrations reached low to normal levels after 
discontinuing treatment. Finally, animals that received both estradiol and subsequently progesterone had 
LH peak concentrations within normal for intact bitches [68,74]. This study supports the notion that in 
bitches, it is not a threshold concentration of estradiol that elicits the positive feedback mechanism with 
the hypothalamus but instead the decreasing ratio of estrogen to progesterone observed in late proestrus 
and early estrus. During estrus, follicles reach 9-12 mm in diameter and achieve their final growth after 
the LH peak has occurred [72]. Ovulation occurs 48-60 hours after the LH surge and is likely triggered by 
the surge induced increase in intra-follicular progesterone due to luteinization of the follicular walls 
before release of the oocyte [46,75,76].  
As in cattle, diestrus is the progesterone dominated stage of the canine estrous cycle and lasts an 
average of 65 days (+/-2 days – counting from the day of the LH peak [77]). Progesterone in the bitch 
starts to rise before ovulation; therefore, diestrus is defined behaviorally as starting once behavioral estrus 
ceases [46,67,69].  Clinically, diestrus starts with the reappearance of non-cornified cells and neutrophils 
on cytological examination and disappearance of vaginal mucosa crenulation [47,66]. Progesterone 
increases through diestrus to peak levels between 15-80 ng/ml until day 20-35 and slowly starts to decline 
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thereafter. The end of diestrus is generally defined by consistent serum concentrations of progesterone 
below 1-2 ng/ml [48,68,70]. The corpus luteum is mostly composed of theca cells with expression of 
prolactin receptors [78]. Prolactin in the bitch is a potent luteotrophic agent and LH and prolactin are both 
required for maintenance of the canine corpus luteum past day 25 post LH peak [46,68,79]. Diestrus and 
pregnancy are the same length in the bitch. The end of pregnancy in this species has a similar underlying 
mechanism as in other species in which fetal adrenal cortisol secretion initiates the cascade of PGF 
production, luteolysis, decrease in plasma progesterone concentrations and production of oxytocin 
[80,81]. The decline in plasma progesterone concentrations below 1-2 ng/ml occurs 8-12 hours before 
parturition. On the other hand, the non-pregnant bitch lacks an acute luteolytic mechanism and 
endogenous PGF appears to be little if at all involved [46,82]. The canine endometrium has the capacity 
to produce PGF [83], but it is negligible since hysterectomy does not prevent luteolysis [84]. The corpus 
luteum has prostaglandin producing capabilities and an autocrine mechanism for luteolysis has been 
proposed in the non-pregnant bitch [85]. Regression of the corpus luteum is progressive and a slow 
decrease in progesterone is observed 20-30 days after the LH peak [64,78,86]. Both pregnant and non-
pregnant bitches have comparable levels of progesterone but the pregnant bitch is thought to have higher 
progesterone levels that are quickly metabolized in the placenta, which is reflected in similar plasma 
progesterone concentrations to non-pregnant bitches [64,87]. In both, progesterone reaches basal 
concentrations by day 60-70 after the LH peak.   
Anestrus is the stage of the estrus cycle in the bitch characterized by lack of overt ovarian 
activity; it is non-seasonal and lasts between 2 to 10 months [68,88]. Clinically, anestrus is characterized 
by the presence of basal and parabasal epithelial cells on vaginal cytology. Vaginal endoscopy reveals 
thin and pink vaginal folds with no crenulation or edema [47]. Estradiol during anestrus remains low. LH 
and FSH are secreted in pulses and mostly coincide with each other. Average LH concentration remains 
low and there is no difference in mean LH and AUC between early, mid and late anestrus [89]. Average 
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FSH concentrations, on the other hand, are high and even more so during late anestrus [89] indicating an 
important role of FSH in the beginning of folliculogenesis in this species. FSH is responsible for the 
increased expression of LH receptor in follicular theca cells [90]. During the last 2 weeks before 
Proestrus, LH pulse frequency increases from one pulse every 6-24 hours to one pulse every 60-90 
minutes [71,91,92]. This supports the hypothesis that although FSH is necessary for early 
folliculogenesis, LH is critical for the termination of anestrus and final growth of follicles in the bitch 
[92]. Administration of LH but not FSH, during late anestrus elicits an early onset of proestrus in the 
bitch [93]. GnRH agonist administration can also induce a fertile estrus within 3-4 days when 
administered continuously during late anestrus [94]. Down regulation of LH secretion by GnRH agonists 
is a slow process and isn’t achieved until 3-4 weeks after starting treatment [46]. In late anestrus, 1-2 
antral follicles of 1-2 mm in diameter can be detected as soon as 50 days before the start of proestrus. 
These numbers increase to 8 per ovary at proestrus [72].  
2.3 HYPOTHALAMIC NEUROPEPTIDES 
Ever since Karsch described the regulation of GnRH secretion by gonadal steroids [5] research on 
the HPG axis has focused on determining the key players in transmitting that effect. After discovering 
that GnRH neurons did not possess steroid receptors [7,95] it became clear that this effect of gonadal 
steroids on the hypothalamus was not direct. And so came the discovery of hypothalamic neuropeptides 
involved in reproductive physiology. 
Gonadotropin releasing hormone is released from the POA in the hypothalamus into the portal 
vein system and reaches the pituitary to stimulate the release of LH and FSH. When and how much 
GnRH is secreted is regulated by the feedback mechanisms involving gonadal steroids. Until recently, the 
mediator between gonadal steroid and GnRH release was unknown. The Kiss1 gene was discovered in 
1996 as a mediator of metastasis in a cancer research laboratory in Hershey, PA, and its product was 
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named KISSpeptin, after Hershey’s famous KISS chocolate [96]. But it wasn’t until the identification of 
its receptor, GPR54, that its role in reproduction was discovered. A negative regulator of GnRH and LH 
secretion has also been recently described. Gonadotropin inhibiting hormone was first discovered in the 
quail and then found to have significant effects on LH secretion in ewes. The following section dives into 
the main neuropeptide studied in this dissertation, GnIH, and other important neuropeptides involved in 
regulation of reproduction such as kisspeptin, dynorphin and neurokinin B. 
 2.3.1 Gonadotropin Inhibiting Hormone 
In recent years an inhibitor of GnRH and gonadotropin secretion was discovered in quails and 
named gonadotropin inhibiting hormone. In mammals, GnIH is a RF-amide neuropeptide that has been 
identified as a negative regulator of reproduction. The discovery, localization and mechanism of action 
are described below. 
  2.3.1.1 Discovery 
The first RF-amide related peptide, FMRF-amide a cardioexitatory neuropeptide in mollusks, was 
isolated in the 1970’s [97]. Later studies in vertebrates, suggested the presence of similar peptides within 
the nervous system, specifically the hypothalamus and pituitary [98,99]. Avian gonadotropin inhibiting 
hormone (GnIH) was first discovered by Tsuisui et al. in 2000 as they were pursuing expression of RF-
amide related peptides in the nervous system of Japanese quail [8]. The isolated peptide from quail brain 
was shown to be located in the hypothalamic-hypophysial area initially by ELISA [8] and subsequently 
confirmed by immunohistochemistry [100,101]. Physiological relevance of GnIH became evident when it 
was discovered to suppress LH secretion from quail cultured pituitary cells [8]. GnIH was also discovered 
to inhibit GnRH induced LH secretion and to decrease breeding in free range sparrows [102]. Using gene 
database searches, Hinuma et al was able to identify two RF-amide peptide genes in human, rat, bovine 
and mouse [103]. In mammals, these inhibiting orthologues of avian GnIH were shown to be present in 
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various species and called RF-amide related peptides 1 and 3 (RFRP-1/3) [104]. These peptides have a C-
terminal sequence of Leu-Pro-Xxx-Arg-Phe-amide; Xxx being Gln or Leu for RFRP-1 and RFRP-3 
respectively [103,104]. The last three amino acids before the N terminal RF-amide motif are widely 
conserved and appear to be responsible for the biological activity of GnIH across species [9,13,103-106]. 
Because this inhibitor appears to have the same physiological effect on mammals as it does in birds, the 
original nomenclature, GnIH, has been extended to all species. Of specific importance to this dissertation, 
the active bovine sequence was isolated and characterized from bovine hypothalamus as VPNLPQRF-
amide which was shown to bind to its G protein coupled receptor (GPR147) and have full cAMP 
production-inhibitory capabilities [107]. Furthermore, this sequence was administered in-vivo to male 
calves and ovariectomized ewes and was able to decrease plasma LH concentrations [9]. 
  2.3.1.2 Cells, fibers and receptor localization 
Initial studies into the localization of GnIH neurons in mammals were carried out using avian 
polyclonal antibodies [36,108]. These studies suggested the presence of GnIH neurons in the dorsomedial 
nucleus of the mouse and rat brain with some clusters in the ventromedial and tuberomamillary nucleus in 
rats. Localization of GnIH cells to the dorsomedial hypothalamus in the rat, hamster and mice was 
confirmed by immunohistochemistry and in-situ hybridization [109]. This distribution of GnIH neurons 
within the dorsomedial nucleus is largely maintained in the ovine hypothalamus as observed in studies 
using in-situ hybridization and immunohistochemistry [9,11,35]. In the non-human primate, 
immunoreactive cells are largely found in the periventricular nucleus with projections into the stria 
terminalis and paraventricular nucleus of the thalamus [34]. 
GnIH fibers project to different areas of the brain depending on species. In the rat and non-human 
primate, fibers extend mostly to the preoptic area, septum and diagonal band of broca [34]. In sheep GnIH 
neuron fibers were seen in close apposition to GnRH neurons in the hypothalamus [11] as well as 
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projecting to the lateral hypothalamus, ventromedial and arcuate nucleus [110]. This apposition of GnIH 
fibers and the distribution within the hypothalamus suggests a direct role of GnIH on GnRH neurons 
[35,36,109] and a potential role in the regulation of appetite [34,110]. In addition, GnIH neuronal fibers 
have been identified projecting into the median eminence of the pituitary in sheep [9,35]. These terminals 
have also been visualized in hamsters [109], primates [34] and humans [111] but not in rats [36,112], and 
are suggestive of a hypophysiotropic role of GnIH in these species.  
Localization of receptors in the brain allows insight into the mechanism of action of different 
neuropeptides. The GnIH receptor (GnIH-R), is a G-protein coupled receptor identified in the brain of 
various species [35,113,114]. It was first identified as a receptor for neuropeptide FF (NPFF1[107]) and 
then identified as a G protein coupled receptor (GPR147) and termed RFR-2 [115]. Expression of GnIH-
R in the hypothalamus was first described in the rat [103] using PCR, in the same study that identified the 
mammalian sequence of GnIH. A moderate level of expression was also observed in the thalamus, mid-
brain, medulla, eye and testis. The highest expression of GnIH-R was within the periventricular nucleus 
of the hypothalamus [103]. GPR147 has been cloned in the sheep [35], rat [103], mouse [116], bovine 
[116] and chicken [117]. In sheep, GnIH-R can be identified in the suprachiasmatic, supraoptic and 
periventricular nucleus of the hypothalamus and the pars tuberalis of the pituitary [35]. The presence of 
GnIH-R in gonadotropes of sheep was later confirmed using percoll gradient cell separation techniques 
[118] in which gonadotrope fractions showed distinct expression of GPR147 as did the lactotrope 
enriched fraction although authors describe gonadotrope contamination in the lactotrope fraction [118]. In 
humans the presence of GnIH-R in the pituitary is less clear. Earlier studies [114] showed that expression 
was barely detectable in human pituitary but more recent studies by Ubuka and others showed labelling of 
gonadotropes with a GPR147 probe [111]. Given the identification of fiber projections into GnRH 
harboring parts of the brain, it is likely that GnIH has a direct effect on GnRH neurons. GnIH-R has been 
shown to be expressed in GnRH neurons of birds [119,120], hamsters [121] and mice [122]. It has also 
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been found in other organs such as the gonads of lizards [123] and mice [124] suggesting a role in 
folliculogenesis and steroidogenesis [124]. 
GnIH neurons themselves also possess important receptors that contribute to their role in the 
regulation of reproduction. GnIH neurons possess steroid receptors and have been hypothesized to 
mediate the control of GnRH secretion by gonadal steroids. The hamster has been the only animal up to 
date that has been shown to express ERα in 40% of GnIH neurons using double labeling 
immunohistochemistry for GnIH and ERα [109]. In female hamsters, gene expression of GnIH changes 
with the stages of the estrous cycle indicating a direct effects of estrogen on these neurons or on neurons 
with projections to GnIH cells [125]. 
It is clear that GnIH is involved in the regulation of the HPG axis. What remains to be elucidated 
is the mechanism through which GnIH exerts its effects. As mentioned in the next section, not only will 
the overall effects of GnIH depend on morphological and anatomical distribution of GnIH neurons and 
GnIH receptors but also on differences in species, reproductive status and breeding patterns of the 
different animal models. 
  2.3.1.3 Regulation of reproduction by GnIH 
Insight into the effects of GnIH is  gained by reviewing localization of GnIH neurons, projections 
of GnIH neurons, GnIH receptor expression in other cell types, receptor expression on GnIH cells 
themselves and ultimately, in-vivo and in-vitro experiments with GnIH treatments. The main effect of 
GnIH on the reproductive system is the decrease of LH concentrations. GnIH has also been shown to have 
an effect on seasonality, food intake and stress mediated effects on reproduction.  
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Role of GnIH on gonadotropin secretion 
The overall effect of GnIH in reproduction is to decrease LH concentrations. There are different 
hypotheses as to how GnIH achieves this and it depends largely on the species and reproductive status of 
the different animal models. 
In all species studied, GnIH immunoreactive (ir) neurons have been found in the hypothalamus 
and appear to have projections to the POA where the majority of GnRH neurons can be found [11,34]. 
Intracerebroventricular (ICV) injection of GnIH has been shown to have direct effects on activation and 
firing of GnRH neurons [126]. Ovariectomized rats were subjected to a hormonal protocol to induce a 
GnRH/LH surge and administered GnIH by ICV injection at different doses. In this study, analysis of the 
immediate early gene c-Fos in GnRH neurons showed a dose dependent decrease in GnRH neuron 
activation by 50-60% at the expected time of the GnRH/LH surge when compared to vehicle-treated 
controls [126]. In an electrophysiological study carried out in mice that had green fluorescence protein 
tagged GnRH neurons, GnIH had a repeatable inhibitory effect on 41% of GnRH neurons [127]. 
Interestingly in this study, 9% of GnRH cells showed increased firing after GnIH treatment.  
Intracerebroventricular injection of GnIH in hamsters and gonad intact rats showed a decrease in plasma 
LH concentrations but LH remained unchanged when ovariectomized and ovariectomized estrogen 
treated rats were administered GnIH ICV [126,128]. GnIH-R has been identified in avian GnRH cells 
[119,120], hamsters [121] and mice [122] but in not in non-rodent mammals. Therefore, it stands to 
reason that different species may have different sites of action for this neuropeptide. 
Immunohistochemical findings in mammals lead to the hypothesis that GnIH has a 
hypophysiotrophic effect. In a study carried out by Clarke et al, ovariectomized ewes were given GnIH IV 
infusions and blood samples collected every 5 minutes before, during, and after treatment [9]. Ewes 
treated with GnIH had a lower LH pulse amplitude and LH area unde the curve (AUC) with no effect on 
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prolactin, growth hormone or cortisol [9]. Because GnIH was administered IV, authors concluded that 
their results supported the hypothesis of a hypophysiotrophic effect of GnIH in ewes. The same laboratory 
treated intact ewes during the late follicular phase and found a significant decrease in LH pulsatility 
during the 2 hour treatment period [10]. Gene expression carried out in that same study suggested a 
decrease in GnIH gene expression during the late follicular phase (prior to ovulation) suggesting a role in 
the increased LH pulsatility during this phase of the estrous cycle (removal of an inhibitory signal for 
GnRH/LH secretion) [10]. To test this hypothesis, ovariectomized ewes treated with estradiol benzoate to 
elicit a surge in LH were given IV infusions of GnIH and frequent blood samples were taken to measure 
plasma LH concentrations. The LH surge was completely blocked in ewes that received IV GnIH 
treatments [10]. The direct effects of GnIH on the pituitary are also evidenced by the presence of pulsatile 
secretions of GnIH in portal blood [118]. In this study, GnIH was measured in the portal blood at 
different stages of the estrus cycle and during the non-breeding season in intact ewes. GnIH pulse 
amplitude, frequency and mean GnIH concentration was found to be higher during the non-breeding 
season compared to the luteal phase of the estrus cycle but there was no difference in mean GnIH 
concentrations or pulse characteristics between the luteal and follicular phase of the estrus cycle [118]. 
The same study found GnIH receptors in gonadotropes by RT-PCR in gonadotrope, lactotrope and 
somatotrope enriched pituitary fractions but mRNA for GPR147 was higher in the gonadotrope enriched 
fraction [118] which indicate a hypophysiotrophic role of GnIH and a potential role of GnIH on prolactin 
and growth hormone regulation. 
In-vitro studies also suggest a hypophysiotrophic role of GnIH. GnIH decreased GnRH 
stimulated LH secretion from ewe primary pituitary cultures in a dose dependent manner [9]. Treatment 
with GnIH showed inhibition of mobilization of intracellular calcium [9] and inhibition of LHß subunit 
mRNA and phosphorylation of ERK 1/2 in ewe pituitary cell cultures [129]. This decrease in LH 
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concentrations in-vitro was also observed in primary pituitary cell cultures of female intact sexually 
mature cattle which were concurrently treated with GnRH [13]. 
Despite these findings, the hypophysiotrophic role of GnIH is still controversial. 
Immunohistochemical and retrograde tract-tracing studies in the rat have not been able to show 
projections of GnIH neurons to the median eminence [112] but IV administration of GnIH in this species 
does decrease LH secretion [128]. It is important to note that in the study suggesting  no 
hypophysiotrophic role of GnIH in rats, ovariectomized animals did have a significant decrease in LH 
secretion 5 minutes post treatment but at no other time point when GnIH was co-administered with 
GnRH. This decrease would be consistent with the expected half-life of 6 minutes for a single injection of 
GnIH [118] and potentially the reason why the decrease was not detected in animals that were not co-
treated with GnRH.  
The rat is not the only animal with controversial results when it comes to the effects of GnIH. 
Experiments carried out in mares were unable to find any effect of GnIH treatment on LH concentrations 
[130]. The equine GnIH sequence was isolated and administered intravenously and subcutaneously at 
different stages of the estrus cycles in mares. Animals during the luteal phase were given a subcutaneous 
(SC) implant of GnIH and co-treated with GnRH. Another study evaluated IV GnIH administration 
during the late follicular phase and finally in anestrus mares under a GnRH challenge. There was no effect 
of IV or subcutaneous administration of GnIH on LH concentrations in peripheral or pituitary sinus blood 
plasma in mares [130].  Although peripheral administration of GnIH had no effect on LH secretion in this 
species, there are no studies on GnIH neuron localization and projections within the hypothalamus in 
mares. It is possible that as for the rat, the regulation of the HPG axis in the mare by GnIH is at the level 
of the hypothalamus and not the pituitary.  
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In vitro studies in the pig revealed an effect of GnIH on GnRH secretion from hypothalamic cell 
cultures at intermediate doses but not at higher doses [131]. Researchers also evaluated the effects of 
GnIH on gonadotropin secretion and expression of gonadotropin gene subunits in porcine pituitary cell 
cultures. LH secretion and LHß subunit expression were decreased in pituitary cultures co-treated with 
GnIH and GnRH [131]. In vivo studies in pigs revealed a decrease in LH concentrations when injected 
peripherally and ICV. Effects on LH pulse amplitude and mean LH concentrations were observed after 
the treatment period at low doses (4.5 ug/kg/hr). When authors increased the number of GnIH injections 
during the treatment period (20 ug/kg/hr), they observed a decrease in the number of LH pulses but no 
other LH pulse characteristics. When administered ICV, 10 ug of GnIH decreased the number and 
amplitude of LH pulses but not mean concentrations of LH. It is unclear from the description of this last 
study whether this was a continuous or single dose administration [132]. It is important to point out that 
gilts used in these experiments were pre-pubertal and therefore results may not be extrapolated to intact 
mature animals. Studies in GnIH-R null mice did not show any influence on the timing of puberty but an 
increase in the litter size in mature mice suggesting a role of GnIH on the HPG axis after puberty [133]. 
Interestingly GnIH treatment of porcine granulosa cells decreased estradiol but not progesterone secretion 
in vitro [131]. It is clear from these examples that the overall effect of GnIH on the HPG axis depends on 
species, reproductive status and breeding patterns of the different animal models used. Together these 
studies suggest that the effects of GnIH in other species may be mediated through mechanisms different 
to those observed in birds and sheep. 
Role of GnIH in seasonality  
Seasonal reproduction is governed by secretion of melatonin that converges with the reproductive 
system at the level of the hypothalamus and GnRH secretion [134,135]. Melatonin secretion occurs in 
response to darkness. Therefore, long secretions of melatonin are associated with short winter days and 
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short secretions of melatonin are associated with long summer days [136]. This section addresses our 
current understanding of GnIH as a mediator of seasonal reproduction in different species. 
Initial studies on the influence of GnIH in seasonality were carried out in birds. Melatonin in the 
quail inhibits reproduction. Removal of the pineal gland and eyes in quails resulted in a decrease in GnIH 
mRNA expression and GnIH peptide in the hypothalamus [137]. This was thought to be mediated by 
direct effects of melatonin on GnIH neurons due to expression of melatonin receptor on GnIH neurons of 
the PVN in the quail [137]. If GnIH is a mediator of the effects of melatonin in seasonal birds, one would 
expect seasonal changes in GnIH expression and secretion during different seasons. Hypothalamic blocks 
from quails exposed to long day photoperiods (breeding season) had decreased GnIH concentrations 
when sampled during the light time [138]. Therefore in birds, GnIH is considered an essential mediator in 
the effects of melatonin on the HPG axis for seasonal reproduction. 
In mammals the effects of GnIH as a regulator of seasonality is less clear. Sheep are strongly 
seasonal and will breed during the short days of the year. Melatonin in sheep has a stimulatory effect of 
reproduction since it is high longer during the breeding season [139]. It is possible that during the 
breeding season GnIH in ewes restricts the occurrence of the LH surge. This hypothesis is supported by 
the fact that expression of GnIH decreases during the late follicular phase in this species and that IV 
administration of GnIH to estradiol treated ewes completely ablated the LH surge [9]. GnIH most likely 
also plays a role in the maintenance of reproductive quiescence during the non-breeding season in the 
ewe. GnIH protein expression was found to be higher and 40% more GnIH-ir cells were present in the 
PVN and DMH of ovariectomized estradiol treated ewes during the non-breeding season [11]. This same 
study though, also found no difference in overall GnIH mRNA expression during the breeding and non-
breeding season [11]. Authors suggest a potential difference in the posttranslational processing of the 
GnIH peptide and further studies on GnIH and its related peptides are needed. Another study in the ewe 
showed an increase in GnIH mRNA expression in ewes maintained under an artificial long day light 
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period [35]. This effect disappeared when ewes were kept under severely long photoperiods (>20 hours of 
light) suggesting a modest effect of GnIH as a regulator of seasonality or it may be related to the artificial 
nature of light treatments [35]. GnIH secretion into the portal system in ewes was found to be higher 
during the non-breeding season compared to the luteal phase but not when compared to the follicular 
phase of the estrous cycle [118]. In this same study, GnIH concentrations in portal blood did not differ 
between the luteal and follicular phase of the estrus cycle [118]. Moreover, in Syrian hamsters, a long day 
breeder, GnIH peptide and mRNA was decreased when exposed to a short day photoperiod (non-breeding 
season) [12]. In this same study, Syrian hamsters were pinealectomized and subjected to a short day 
photoperiod or melatonin injections to imitate a short day photoperiod. The decrease of GnIH seen in 
pineal intact animals was ablated by pinealectomy and restituted after 60 days of melatonin injections  
indicating a direct correlation between melatonin and GnIH secretion [12]. The mare is another long day 
breeder in which GnIH does not seem to play a role in the control of seasonal breeding. Mares treated IV 
with GnIH during the late follicular phase and in anestrus together with GnRH did not decrease plasma or 
pituitary sinusoidal LH concentrations [130]. 
These results indicate that GnIH remains a controversial candidate as a regulator of seasonality in 
mammals. It is possible that GnIH plays a role in seasonality and the regulation of the estrous cycle in 
species such as ewes, but more studies are needed to determine the level at which GnIH exerts these 
effects on the HPG axis. 
  2.3.1.4 Other physiological roles of GnIH 
Role of GnIH in metabolic state related effects on reproduction 
Regulation of food and water intake is essential for maintenance of reproduction. One of the first 
to notice a link between reproduction and energy balance was Charles Darwin in his publication, The 
origin of species [140]. He noticed how domestic animals could achieve greater reproductive success than 
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their ancestors and attributed it to the optimal food supply and the expenditure of minimal energy to 
obtain it for animals such as livestock. He also alludes to the effects of nutrition when he mentions the 
lengthening of the time it takes to conceive in animals experiencing “hard living” [140].  
Initial studies into the effects of food intake regulation and reproduction involved administration 
of steroids and food restriction regimens. Snapir et al [141] treated castrated and intact white leghorn 
cocks with different synthetic gonadal steroids and observed a decrease in body mass and food intake in 
cocks treated with testosterone propionate whether they had been castrated or not suggesting a potent role 
of this steroid in the regulation of food intake [141]. In male rats bilateral implants of testosterone 
propionate in the hypothalamus decreased food intake in castrated animals [142]. Since GnIH neurons 
have projections to several parts of the hypothalamus, including the arcuate nucleus and the lateral 
hypothalamic area where neurons involved in food intake and restriction can be found, it has been 
hypothesized that GnIH may mediate this relationship at the level of the hypothalamus.  
Initial studies evaluating the relationship between GnIH and feeding were carried out in birds. In 
birds most of GnIH neurons are located in the PVN which also houses neurons involved in regulation of 
feeding in birds [143]. Intracerebroventricular (ICV) administration of GnIH in male chicks increased 
food intake compared to control animals [144]. In this same study fasting-induced feeding chicks were 
injected ICV with GnIH antiserum. The anti-serum inhibited the increase in food intake in fasted animals 
when compared to fasted controls treated with normal serum [144]. Similar studies carried out in male 
rats also showed increased food intake when GnIH was administered ICV [36]. Studies involving food 
restriction in female Syrian hamsters revealed activation of GnIH neurons (expression of immediate early 
gene FOS) and expression of GnIH peptide in the hypothalamus and was associated with food hoarding 
and decrease in sexual activities [145]. Interestingly, these results were not correlated with increased food 
intake. Reproductively, these females had decreased vaginal scent marking which is considered a 
proceptive female behavior in the rat [145]. In this study, strong projections were observed from GnIH-ir 
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neurons to NPY-ir cells in the DMH of food-restricted female hamsters. As authors mention, although 
indicative of a potential association, these observations did not prove a definite cause of these behaviors 
by GnIH. 
Using immunohistochemistry and retrograde tracers on hypothalamic sections of sheep, GnIH 
neurons were found to project from the DMN to cells that produce NPY or POMC in the arcuate nucleus 
and to those in the lateral hypothalamus that produce orexin and MCH [110]. Extensive functional studies 
of the effects of GnIH on food intake and reproductive activities were carried out by Clarke et al [10]. To 
evaluate the effects of GnIH on reproductive behavior and food intake, GnIH was infused ICV into the 
brains of ovariectomized ewes, male mice and male macaques. There was no effect of GnIH infusion on 
any reproductive behavior observed but food intake was significantly increased in all species studied [10].  
These studies suggest that GnIH serves as a mediator between reproduction and the regulation of 
feeding in the species studied up to date. 
Role of GnIH in stress related effects on reproduction 
Prolonged stress has been shown to decreased reproduction in mammals [146]. During stressful 
events, the hypothalamic-pituitary-adrenal (HPA) axis is activated [147]. Neurons that secrete 
corticotrophin-releasing hormone (CRH) in the PVN are activated and CRH is released into the venous 
portal system where it reaches the corticotropes in the anterior pituitary. In turn corticotropes release 
adrenocorticotrophic hormone (ACTH), β-endorphin and α-melanocyte-stimulating hormone (MSH) 
[147]. Adrenal gland release of glucocorticoids is stimulated by ACTH. Glucocorticoids in turn regulate 
the secretion of CRH and ACTH by a negative feedback mechanism on the pituitary and hypothalamus 
[148]. The other system activated during a stressful event is the sympathetic nervous system where 
noradrenaline is secreted onto the adrenal medulla stimulating production of catecholamines [149]. Beta 
endorphins are more likely to play a role in instances of acute stress, but the effects of short term stressful 
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events on reproduction is less clear. In conditions of chronic stress, GnRH and gonadotropins can be 
inhibited by glucocorticoids [146]. Because GnIH is a mediator in the negative regulation of LH, it 
reasons to hypothesize that GnIH could be a player in the down regulation of reproduction by stress. 
Studies carried out in sparrows found an increase in GnIH-ir cells when captured during the 
breeding season [150]. Authors later reported that these effects were mediated through glucocorticoids 
and glucocorticoid receptors expressed in GnIH neurons [151]. Similar studies were carried out in the rat. 
Male Sprague-Dawley rats were subjected to acute and chronic immobilization stress and hypothalami 
evaluated for GnIH cells (IHC and in situ hybridization), GnIH mRNA and GnIH peptide [152]. GnIH 
mRNA and peptide expression were increased in animals subjected to acute and chronic stress and lasted 
up to 24 hours after the end of immobilization in animals under chronic stress conditions. Rats also had an 
inverse correlation between GnIH mRNA levels and circulating concentrations of LH [152]. In this same 
study, double immuohistochemical labelling revealed 53% of GnIH cells express glucocorticoid receptor. 
Lastly adrenalectomy in these rats prevented the stress related increase in GnIH mRNA in the 
hypothalamus [152]. A more recent study in female rats revealed that chronic stress stopped 4 days before 
mating resulted in fewer copulations, pregnancies and number of embryos [153]. These animals had 
higher GnIH mRNA and GnIH receptor expression during all stages of the estrus cycle post stressor. 
These effects were not evident in rats that had GnIH expression knocked down with the use of siRNA 
reinforcing the role of GnIH in the mediation of inhibition of reproduction during conditions of chronic 
stress in the rat [153].  
The role of GnIH in stress mediated reproductive suppression is not evident in all species. 
Ovariectomized Corriedale ewes subjected to isolation/restraint stress for 90 minutes prior to collection of 
their hypothalami for in situ hybridization and immunohistochemistry of GnIH had higher plasma 
concentrations of cortisol and lower plasma LH concentrations during the treatment period as compared 
to non-stressed controls [154]. In situ hybridization showed no difference in the number of cells 
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expressing GnIH mRNA. There was no difference in number of cells immunostained for GnIH peptide 
between stressed and control animals [154].  
These results indicate that GnIH remains a controversial candidate as a mediator of stress-induced 
effects on reproduction. More studies are needed to determine whether effects seen in the rat are 
conserved among other species and the level at which GnIH exerts these effects on the HPG axis in other 
mammals. 
 2.3.2 Other hypothalamic neuropeptides 
  2.3.2.1 Kisspeptin 
Kisspeptin plays a pivotal role in the regulation of reproduction in mammals. Until the discovery 
of kisspeptin, no available information could explain the regulation of GnRH secretion by sex steroids 
since these neurons lack ERα, important for the transmission of gonadal steroid effects onto the brain 
[7,95]. The first indication as to the importance of KP in such a role was with the discovery that a 
mutation in the kisspeptin receptor GPR54 led to a hypogonadotrophic hypogonadism phenotype in 
humans and mice [14]. This discovery was made by two different labs the same year and led to major 
advancement in the area of reproductive endocrinology in the last decade [14,15]. 
The KISS 1 gene encodes the precursor peptide for kisspeptin that is 52-54 amino acids long 
[155]. This precursor is then cleaved and the resulting active peptide is highly conserved among domestic 
species [156]. The minimum sequence of kisspeptin needed is 10 amino acids long from the c-terminal 
[157] and is identical in small ruminants, cattle, pig, rat and human with the exception that in primates 
tyrosine is replaced with phenylalanine [157,158]. Kisspeptin neurons are located in two major regions of 
the hypothalamus, the ARC and the POA but this can vary among species. In rodents for example, Smith 
et al showed with the use of in situ hybridization that kisspeptin neurons are located in the ARC, AVPV 
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and PeV region of the hypothalamus and that such expression can be differentially altered by sex steroid 
concentrations (gonadectomy and gonadal steroid treatment)  in both female and males [31,32]. More 
specifically, Kiss-1 mRNA was increased in the ARC after gonadectomy and was reversed with gonadal 
steroid replacement. The opposite was true in the AVPV where gonadectomy reduced kiss-1 expression 
and gonadal steroid replacement increased kiss-1 expression [31,32]. Authors propose kisspeptin neurons 
in the ARC as mediators of the negative feedback mechanism of GnRH by gonadal steroids (tonic center) 
and kisspeptin neurons in the AVPV as mediators of the positive feedback mechanism of GnRH by 
gonadal steroids during the LH surge (surge center) in rodents [31,32]. In sheep, the distinction is not as 
clear. In general Kiss-1 expressing neurons in the POA are considered to mediate the positive feedback 
mechanism of GnRH by gonadal steroids and increases just prior to the pre-ovulatory LH surge [28]. 
Estradiol treatment can also increase the expression of Kiss-1 in the POA and, therefore, is considered the 
equivalent area as the AVPV in mice [11]. Interestingly, in the sheep, only 50% or less of kisspeptin 
neurons in the POA express ER alpha suggesting an indirect regulation of Kiss-1 expression by estradiol 
[159]. The ARC in the sheep, as opposed to the rodent ARC, is involved in both positive and negative 
feedback of gonadal steroids. It appears that cells in the caudal ARC play an important role in the pre-
ovulatory GnRH/LH surge [26,28] and that the entire ARC can respond to chronic levels of estradiol 
(negative feedback mechanism) [160]. Estrada et al, analyzed hypothalamic samples of ewes at different 
stages of the estrus cycle and found that there was an increased expression by in situ hybridization of kiss-
1 mRNA in the caudal hypothalamus in the late follicular phase  (determined by LH concentrations 
between 1.4-6.9 ng/ml) [26,161]. The differential response of the ARC neurons to estradiol may be 
explained by the differences in the signaling pathways of ERα [162]. Classical ERα signaling requires 
translocation of ERalpha into the nucleus and recruitment by the receptor of cofactors onto the estrogen 
response elements in the DNA. The non-classical signaling pathway involves estrogen response element 
(ERE) independent mechanisms involving interaction with transcription factors [162,163]. Through a 
series of experiments with ERα knock out mice that were then used as a background for a knock in of the 
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ERα ERE independent signaling pathway showed that animals were still not able to ovulate (absence of 
corpus luteum) but could return LH concentrations back to intact levels in OXV mice treated with basal 
and pre-LH sure levels of estrogen. ERα KO mice had no change in LH levels with estrogen treatment 
[163]. Authors concluded that the ARC mediates both positive and negative steroidal feedback though 
classic and ERE mediated signaling respectively of the ERα. A similar model was used to measure kiss 1 
mRNA in the ARC. In OVX mice with a mutated ERα that cannot bind to ERE sites, estrogen inhibits 
kiss-1 in the ARC suggesting that the regulation of kiss-1 by estradiol in the ARC involves ERα ERE-
independent signaling pathways [162]. 
Kisspeptin causes GnRH secretion from the hypothalamus and is therefore considered to have a 
direct effect on GnRH neurons. From the studies mentioned above, we can also infer that kisspeptin is the 
mediator between sex steroids and GnRH secretion [162]. GnRH neurons do not possess ERα [164,165] 
but over 60% of kisspeptin neurons in female mice do [166]. In the sheep, almost all kisspeptin neurons 
express ERα in the ARC and about 50% of those in the POA [159]. In the ewe, kisspeptin neurons in the 
ARC express dynorphin (DYN) and neurokinin B (NKB) which have been suggested to play a role in the 
mediation of the effects of estrogen and progesterone on kisspeptin neurons [167].  The direct effects of 
kisspeptin on GnRH neurons in vitro were also observed by studies in which peripheral kisspeptin 
injection elicited c-Fos activation of GnRH neurons [168]. Studies of electrical activity in hypothalamic 
sections of male and female mice showed an increase in depolarization in over 90% of green fluorescent 
GnRH neurons when treated with kisspeptin [168].  
In vivo studies support the notion that kisspeptin elicits a direct action on GnRH neurons. 
Ovariectomized ewes fitted with estrogen implants and cannulas into the lateral ventricle of the brain 
were treated ICV with kisspeptin [169]. Peripheral blood was tested for LH and cerebrospinal fluid for 
GnRH. Results showed a significant increase of LH and GnRH within two minutes of starting ICV 
infusion [169]. Administration of antagonists attenuates the effects of kisspeptin administration in several 
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species. For example, there was no increase in LH in male rats that were pre-treated with acycline (GnRH 
antagonist) then treated with kisspeptin ICV when compared to those only treated with kisspeptin [170]. 
A very extensive study was carried out in sheep, rats and monkeys that tested the kisspeptin antagonist, 
peptide 234 [171]. In this study peptide 234 was infused in the stalk median eminence region and 
cerebrospinal fluid (CSF) was sampled for GnRH measurement. GnRH concentrations and pulse 
frequency were consistently suppressed during the treatment period in comparison to the period before 
infusion and compared to control animals [171]. There are controversial results regarding the direct 
effects of kisspeptin on pituitary gonadotropes. In sheep, some kisspeptin receptor (KISS1R) expression 
can be seen in the pituitary gland but no detectable levels of kisspeptin can be found in portal circulation 
[172]. In this study, hypothalamic-pituitary disconnected ewes treated with GnRH and kisspeptin did not 
have different LH secretion as compared to controls [172] indicating no direct effects of kisspeptin on 
pituitary gonadotropes. On the other hand, varicose fibers from kisspeptin neurons are in close contact 
with GnRH fiber projections at the median eminence in the rhesus monkeys [29]. Treatment of mouse 
median eminence with kisspeptin stimulates the release of GnRH [173]. Also peripheral administration of 
kisspeptin in several species has shown to increase LH levels. For example, IV administration of 
increasing doses of kisspeptin in prepubertal gilts showed an increase in peripheral concentrations of LH 
but not growth hormone indicating a potential site of action for kisspeptin beyond the blood brain barrier 
[174]. This effect is also true for cyclic and anestrus ewes in which IV injections and constant rate 
infusions of human or mouse kisspeptin increased plasma LH levels [175]. Each increase in plasma LH 
levels was also associated with a previous increase in GnRH levels in CSF [175]. These studies strongly 
suggest a mechanism of action other than directly on GnRH neuronal bodies. It has been suggested that 
kisspeptin may regulate GnRH secretion through axo-axonic connections at the level of the median 
eminence [176]. Further studies are warranted to determine the exact mechanism of action of peripheral 
administration of kisspeptin.  
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The role of kisspeptin in seasonality has been extensively studied in the ewe. In this species it is 
the increase of the negative feedback effect of estrogen on the HPG axis that causes seasonal anestrus 
[177,178]. This change in sensitivity is thought to be mediated through kisspeptin. Ovariectomized ewes 
treated with estrogen implants showed that the inhibitory effects on KISS 1 mRNA and kisspeptin 
expression in the ARC were greater during the non-breeding season [11]. This estrogen dependent effect 
was not seen in the POA. Authors concluded that the differences in seasonal sensitivity to estrogen are 
mediated by kisspeptin cells in the ARC in ewes. It remains to be determined whether there are seasonal 
changes in ERα in the ARC of sheep. The number of kisspeptin-ir cells was 4-fold higher in the ARC of 
ewes during the breeding season but was similar in the POA supporting the notion that the ARC mediates 
both the negative and positive feedback mechanism of steroids on the HPG axis [11]. These effects of 
seasonality on kisspeptin expression are thought to be mediated through melatonin [179]. Syrian hamsters 
are long day breeders; therefore, under the influence of extended release of melatonin (short days) 
hamsters are reproductively quiescent [180]. When Syrian Hamsters were exposed to short day 
photoperiod, KISS 1 expression declined [181]. This decline in KISS 1 expression was lost if animals 
were pinealectomized before exposure to a short day photoperiod therefore suggesting a regulation of 
KISS 1 expression by melatonin in the Syrian Hamster [181]. No studies have been carried out in the ewe 
to determine whether the effects of photoperiod on kisspeptin in this species is mediated through 
melatonin, although no melatonin receptors have been found in the ovine brain [182]. Although melatonin 
is the main hormone that translates photoperiod into a chemical signal within the brain, it is possible that 
regulation of kisspeptin by melatonin is carried out through intermediate cell types [183].  
In summary, kisspeptin is a pivotal neuropeptide in the regulation of reproduction in mammals. 
Kisspeptin is thought to be the counterpart to GnIH in the regulation of reproduction although the role of 
kisspeptin in the regulation of reproduction appears to be more delineated than for GnIH.  
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  2.3.2.2 Neurokinin B 
The majority of neurons in the ARC of humans (70% [184]), mouse (85-95% [185,186]), rat 
(97% [187]), sheep (80-94% [188]) and goat (80-99% [16]) co-express two other neuropeptides 
implicated in the regulation of GnRH secretion, neurokinin B (NKB) and dynorphin (DYN). Because of 
the prevalent co-localization of these neuropeptides, these neurons in the ARC are referred to as KNDy 
neurons [189]. 
Neurokinin B is a member of the tachykinin family of peptides encoded by the TAC3 gene in 
humans [190], dogs, non-human primates and cattle [191,192], and TAC2 in rodents [193]. It was first 
discovered to play a role in gonadal steroidal feedback in the 1990’s [194] when increased expression of 
NKB and kisspeptin were found in the hypertrophied infundibular nucleus of post-menopausal women. In 
situ hybridization and microhistochemistry for NKB expression was analyzed in hypothalamic sections of 
ovariectomized monkeys [195]. In the absence of steroidal feedback (ovariectomy), authors found that 
neurons in the basal hypothalamus were hypertrophied and had elevated expression of NKB [195]. 
Hormone replacement therapy after ovariectomy reversed hypertrophic changes and decreased NKB 
expression supporting the hypothesis that NKB is a key player in the transmission of gonadal steroid 
feedback at the level of the hypothalamus [195]. Co-expression of NKB and ERα has been found in rats 
[196], human [194] and sheep [197]. Gene expression of NKB in the rat changes with the stages of the 
estrus cycle [198] and ovariectomy increases NKB gene expression in non-human primates [195]. All of 
this evidence points to an important role of NKB in the regulation of the HPG axis.  
Mutations of NKB receptor (TACR3 or NK3R) were shown to cause hypogonadism in humans 
very much like mutations in the kisspeptin receptor [199] indicating a major role for NKB in the control 
of GnRH secretion and puberty. Humans with this mutation do not go through puberty and have low 
levels of LH [200]. Pulsatile GnRH administration in an affected female allowed for ovulation, pregnancy 
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and normal delivery indicating that the mutation directly affects the hypothalamic control of gonadotropin 
secretion and not the pituitary or gonads [200].  These characteristics in affected humans, suggested a 
stimulatory action of NKB. This was later confirmed when ovariectomized goats were given an ICV 
injection of NKB and multiple unit electrical activity (MUA) of KNDy neurons in the basal hypothalamus 
was recorded and compared to plasma LH concentrations [16]. Authors found that KNDy neurons had 
periodic MUA volleys and that each of them was associated with an LH pulse. After ICV administration 
of NKB, MUA volleys of the KNDy neurons increased and inter-volley intervals were shorter, though 
these were not associated with a subsequent LH pulse [16]. KNDy neurons have been found to express 
NKR3 and therefore NKB has been hypothesized to have an autocrine effect on the KNDy neuron itself 
[186,196,201]. Therefore it is likely that ICV injection in this study induced desensitization of the KNDy 
neuron decreasing kisspeptin secretion and in turn GnRH and LH secretion [16]. Administration of NKB 
did not produce a sustained increase in MUA, instead it increased the number of episodic volleys of 
MUA. It is hypothesized that there is an inhibitory drive that acts immediately after the release of NKB to 
reduce the stimulatory activity on the KNDy neuron [202]. This inhibitory signal is thought to be 
dynorphin.  
  2.3.2.3 Dynorphin 
Under the influence of progesterone, LH pulse frequency remains low [5,203]. Once luteolysis 
occurs and progesterone levels fall, LH pulse frequency increases and estradiol incurs in a positive 
feedback mechanism with the hypothalamus to elicit the preovulatory LH surge [5]. From this 
description, it is clear that progesterone, like estrogen, has a direct effect on the hypothalamus. GnRH 
neurons do not possess progesterone receptors [95] but virtually all KNDy neurons possess progesterone 
receptor (PR) [204] which makes them a prime candidate in the transmission of the effects of this sex 
steroid onto GnRH neurons. Dynorphin is an endogenous opioid that is co-expressed in KNDy neurons of 
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the basal hypothalamus [17,196] and is thought to be the neuropeptide to mediate the effects of 
progesterone onto GnRH neurons.  
Several studies were carried out in ewes to determine the role of DYN in the regulation of GnRH 
neurons. An endogenous opioid antagonist, WIN, was administered to intact ewes in the follicular or 
luteal phase and ovariectomized ewes treated with progesterone, estradiol or progesterone plus estradiol 
[205]. Treatment of intact ewes during the luteal phase increased LH pulse frequency, but not LH pulse 
amplitude. In contrast, during the follicular phase, LH pulse amplitude was increased by WIN treatment 
but pulse frequency was unchanged. LH pulse frequency or amplitude remained unchanged in long term 
ovariectomized ewes treated with the antagonist. These results suggest a role of endogenous opioids in the 
regulation of the negative feedback mechanism of gonadal steroids on gonadotropin secretion [205]. In 
2004, Goodman and others were able to determine the specific endogenous opioid responsible for the 
mediation of the effects of progesterone on GnRH and LH secretion [206]. Intact black-face ewes were 
treated with κ-, μ- or δ- receptor antagonists during the luteal phase using micro implants near the MBH. 
The κ-antagonist produced an immediate LH pulse in five of the eight ewes and increased LH pulse 
frequency and mean LH levels to values similar to those seen in the positive control group treated with 
naloxone. Dual immunocytochemistry and light microscopy in brains of ewes during the luteal phase 
revealed that 90% of MBH GnRH neurons had close associations with dynorphin-containing varicosities. 
These results led the authors to conclude that dynorphin was a key player in the transmission of the 
effects of progesterone on the hypothalamus [206]. A later study that measured levels of dynorphin in 
CSF found that ewes that were ovariectomized and treated with progesterone had higher levels of 
dynorphin in their CSF than those not treated with progesterone. Ewes that were left intact, had 
intermediate overall concentrations of dynorphin in CSF but these levels increased with increasing 
endogenous progesterone concentrations during the treatment period [207]. These studies confirmed that 
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the endogenous opioid acting on GnRH neurons to decrease GnRH/LH pulses during times of high 
progesterone concentrations is dynorphin.  
2.4 NEUROPEPTIDES AND GNRH PULSE CREATING MECHANISM HYPOTHESIS 
The first indication that reproductive hormones were released in pulses came after the 
development of radioimmunoassays and measurement of LH concentrations in plasma [1]. By 1970 
Knobil et al had described the pulsatile nature of LH secretion in monkeys [208]. Although GnRH was 
discovered in the 1970’s, it was not until the 1980’s that it was confirmed as the regulator of LH secretion 
when Clarke et al were able to measure GnRH in portal blood after placing portal cannulation devices in 
ewes and sampling every 30 seconds for measurement of GnRH [209]. With the study of GnRH release 
into the portal system came the discovery that the preovulatory LH surge was also due to a large 
discharge of GnRH onto the pituitary and not due to accumulating concentrations of LH in circulation 
[210]. The question as to where and how GnRH pulses are generated remains to be fully elucidated. To 
this day the most convincing theory involves the population of KNDy neurons of the ARC. Multi-unit 
activity (MUA) recordings of the MBH were associated with GnRH release in monkeys [24], rats [211] 
and goats [212]. Moreover these MUA were not increased during the LH surge suggesting a different set 
of neurons other than the GnRH neurons themselves as the generators of GnRH pulsatility [213]. Studies 
carried out in goats where electrodes were inserted into the caudal ARC found episodic MUA that were 
associated with LH pulses [16,156]. This together with the identification of kisspeptin neurons in this 
region of the hypothalamus, lead to the theory of KNDy neurons of the posterior ARC as the GnRH pulse 
generator. 
KNDy neurons possess several characteristics that make them attractive as potential GnRH pulse 
generators [202]: they can generate rhythmic oscillations and MUA, they have synchronous activity 
within the population of neurons in the ARC, they are capable of transmitting their rhythmic activity to 
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GnRH neurons and they are capable of transmitting the gonadal steroid feedback due to the expression of 
steroid receptors [202]. One important characteristic of these neurons is the fact that not only do they 
express kisspeptin, NKB and DYN they also express neurokinin B3 receptor (NKR3) and κ opiod 
receptor (KOR) [185,196,201]. Thus, they express the required elements for a paracrine feedback loop 
that would allow this group of neurons to self-regulate. The network that these neurons form is clear from 
studies with dual labeling ARC neurons for kisspeptin, NKB and DYN. In these studies NKB/DYN 
neurons possess close apposition with NKB/DYN fibers [196,204]. The same can be found between 
NKB/DYN and Kisspeptin/DYN neurons in the ARC in the goat [16]. Through electron microscopy, 
kisspeptin neurons have been shown to form close apposition with GnRH neuronal axons in the ME 
although the presence of kisspeptin receptor on these axons remains to be demonstrated [29,214,215].  
These studies support the hypothesis that KNDy neurons possess the neuronal network, interconnections 
and self-regulating abilities to be the GnRH pulse generators. 
Taking into consideration that kisspeptin is the ultimate secretion onto GnRH neurons and that 
NKB activates kisspeptin secretion but DYN inhibits firing of KNDy neurons, the working hypothesis for 
the GnRH pulse generator involves the following [202,216]: KNDy neurons in the ARC form a web 
interconnected by their axon collaterals and dendrites [217] through which they transmit random burst of 
activities mediated by NKB and the NKR3 expressed by KNDy neurons [188,196]. At the same time 
NKB is secreted to initiate a burst of activity [218], DYN is also secreted albeit with a time lag to inhibit 
such burst through the KOR also expressed in KNDy neurons [16]. DYN appears to produce a refractory 
period on KNDy neurons allowing for the episodic burst in MUA of the KNDy neuronal network [16]. 
DYN then sets the negative tone for the episodic burst of activity and NKB sets the stimulatory tone that 
generate the activity oscillations that induce kisspeptin secretion. Each activity burst corresponds to a 
pulse in kisspeptin release onto the GnRH axons in the median eminence which in turn produces a pulse 
in GnRH release into portal circulation [171,173,219]. The frequency of these bursts within the ARC are 
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governed by gonadal steroids with progesterone enhancing the inhibitory tone of DYN [204,207] and 
estrogen inhibiting the stimulatory tone of NKB mediating the negative feedback mechanism of this 
steroid in the hypothalamus [185,220].  
This model for the GnRH pulse generator does not take into account other neuropeptides such as 
GnIH. Part of the reason is that much less is known about the specific roles of GnIH in reproduction. The 
following chapters of this dissertation will attempt to shed light on some of the still unknown aspects of 
the control of reproduction by hypothalamic neuropeptides. Specifically we address the need for 
characterization of GnIH in the bovine hypothalamus and the in vivo role of GnIH in the control of LH 
secretion in this species. Furthermore we also seek to characterize GnIH in the canine as a model for non-
seasonal anestrus and potential non-surgical contraception method. 
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2.5 APPENDIX 
 
Figure 2.1: Hypothalamic anatomy. a) Transverse section of rostral portion of the hypothalamus. 
III: third ventricle; PVN: paraventricular nucleus; PeVN: periventricular nucleus; POA: preoptic area; 
SCN: suprachiasmatic nucleus; SON: supraoptic nucleus. b) Transverse section of middle or tuberal 
portion of the hypothalamus. DMN: dorsomedial nucleus; LHA: lateral hypothalamic area; VMN: 
ventromedial nucleus; ARC: arcuate nucleus. c) Transverse section of posterior or mammillary portion of 
the hypothalamus. PHN: posterior hypothalamic nucleus; MB: mammillary bodies. 
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CHAPTER 3 
OBJECTIVES
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The purpose of the studies carried out for this dissertation was to determine the distribution of 
reproductive neuropeptides in the bovine hypothalamus and to determine the physiological effects of 
peripheral administration of GnIH in intact female cattle and ovariohysterectomized bitches. 
The first study was carried out to determine the distribution and connectivity of kisspeptin, DYN, 
and GnIH neurons in the hypothalami of intact female cattle during either the periestrus or diestrus stage 
of the estrous cycle. We hypothesized that changes in the immunoreactivity of neuropeptides of the 
KNDy and GnIH neurons would correlate to hormone changes related to the ovarian cycle in the bovine. 
The second study was carried out to determine the effects of peripheral administration of GnIH 
on LH concentrations in intact female cattle. We hypothesized that IV administration of GnIH would 
decrease serum LH concentrations in intact female cattle. 
The third study was carried out to determine the effects of peripheral administration of GnIH on 
LH concentrations in ovariohysterectomized bitches. We hypothesized that IV administration of GnIH 
would decrease serum LH concentrations in ovariohysterectomized bitches. 
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CHAPTER 4  
DISTRIBUTION AND REGULATION OF GONADOTROPIN-RELEASING 
HORMONE, KISSPEPTIN, GONADOTROPIN INHIBITING HORMONE 
AND DYNORPHIN IN THE BOVINE HYPOTHALAMUS 
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4.1 ABSTRACT 
Recent work has led to the hypothesis that kisspeptin/neurokinin B/dynorphin (KNDy) neurons in 
the arcuate nucleus play a key role in gonadotropin-releasing hormone (GnRH) pulse generation and 
gonadal steroid feedback, with kisspeptin driving GnRH release and NKB and DYN acting as pulse start 
and stop signals, respectively. A separate cell group, expressing gonadotropin-inhibiting hormone (GnIH) 
has been shown to be a primary inhibitor of GnRH release. Very little is known regarding these cell 
groups in the bovine. In this study, we examined relative immunoreactivity (-ir) of kisspeptin, dynorphin, 
and GnIH and their connectivity to GnRH neurons in the hypothalami of periestrus and diestrus cows. 
While GnRH and GnIH immunoreactivity were unchanged, kisspeptin and DYN immunoreactivity levels 
varied in relation to plasma progesterone concentrations and estrous status. Animals with higher serum 
progesterone concentrations in diestrus had lower kisspeptin and increased DYN immunoreactivity in the 
arcuate nucleus. The percentage of GnRH cells with kisspeptin or GnIH fibers in close apposition did not 
differ between estrous stages. However, the proportions of GnRH cells with kisspeptin or GnIH contacts 
(~49.8% and ~31.3%, respectively) suggest direct communication between kisspeptin and GnIH cells to 
GnRH cells in the bovine. The data produced in this work support roles for kisspeptin and DYN, within 
the KNDy neural network, in controlling GnRH release over the bovine ovarian cycle and conveying 
progesterone-negative feedback onto GnRH neurons. GnIH immunoreactivity was unchanged and thus 
we were unable to demonstrate a role of GnIH in the bovine ovarian cycle.  
4.2 INTRODUCTION 
Release of the decapeptide gonadotropin-releasing hormone (GnRH) into the portal vascular 
system is the final common pathway for the neural control of reproduction. Fibers from GnRH neurons 
project to the external zone of the median eminence and release their neuropeptide into the portal blood 
system; from there, it travels to the pituitary gland to stimulate synthesis and release of luteinizing 
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hormone (LH), and follicle-stimulating hormone (FSH) [221,222]. Under most endocrine conditions, 
GnRH secretion occurs episodically [45]. Although the pulsatile pattern is essential for normal 
reproductive function [223], the mechanism responsible for synchronizing GnRH cell activity remains 
largely unknown. Timing and degree of GnRH release is likely controlled by multiple stimulatory and 
inhibitory factors [224].  
Two RF-amide peptides, kisspeptin and RFamide-related peptide-3 (also referred to as 
gonadotropin-inhibitory hormone [GnIH]), are expressed in the hypothalamus and have been shown to 
stimulate and inhibit GnRH neuronal activity, respectively [8,168,225]. Kisspeptins are the peptide 
product of the KISS 1 gene, stimulate GnRH secretion [226-228] and are critical for reproductive function 
[14,229]. No other factor has been shown to be as potent a stimulator of GnRH neurons as kisspeptin 
[14,226,228,230-238]. In addition, the kisspeptin neurons in the arcuate nucleus (ARC) co-express the 
endogenous opioid DYN, which is inhibitory to pulsatile GnRH release and NKB, a stimulator of GnRH 
release [16,17,188,239]. The neurons co-expressing kisspeptin, NKB, and dynorphin have subsequently 
been coined KNDy (kisspeptin/neurokinin B/dynorphin) neurons [240] and are found in sheep [188], rats 
[187,196], mice [185], goats [16], and possibly women [241-243].  
There is strong evidence that the KNDy cell group is critical for episodic GnRH release 
[171,244]. Kisspeptin is the primary output to GnRH neurons, with direct synapses to GnRH soma and 
fibers in the median eminence that express the kisspeptin receptor GPR54 [11,29,184,227,245-249].  The 
neuropeptide NKB acts within the KNDy network to initiate GnRH pulses and DYN acts to inhibit KNDy 
neural activity, thus terminating each pulse [239]. The proposed actions of NKB are supported by reports 
that the stimulatory actions of the NK3R agonist senktide on GnRH secretion are mediated by kisspeptin 
release from KNDy neurons in several species [186,250-254] and that ICV administration of NKB 
stimulates cell activity in the ARC of the goat and increases LH pulse frequency in the ewe [16,244]. 
Acting as the brake of the KNDy network is the endogenous opioid DYN. The general opioid receptor 
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antagonist naloxone prolongs each GnRH pulse in ovariectomized ewes [255], and central administration 
of the κ-opioid receptor antagonist nor-binaltorphimine increases the frequency of multiple-unit activity 
in the ARC of ovariectomized goats [16] and increases LH pulse frequency in the ewe [239].  
Working through the G protein-coupled receptor GPR147, GnIH has been implicated in the 
negative regulation of LH secretion [8,9,104,111,129,256,257]. The GnIH neurons are mainly localized in 
the dorsomedial hypothalamic nucleus (DMN), from which fibers project to GnRH neurons in the 
preoptic area (POA) in mammals [11,34,109-111,121]. In rodents, GPR147 mRNA is expressed in a 
subset of GnRH neurons [122,258,259]. The main inhibitory effect of GnIH appears to be at the level of 
GnRH neurons in hamsters [260], rats [126,261,262], and mice [225,263]. These findings, along with 
GnRH cell recordings, strongly suggest a direct action of GnIH on GnRH neurons [264]. Immunoreactive 
GnIH projections have been observed in the median eminence of sheep [11,110] and primates [34]. 
Studies in-vivo support this data, in which intravenous administration of GnIH decreased plasma LH 
concentrations during the late follicular phase of the estrous cycle in intact ewes and during an estradiol 
benzoate-induced LH surge in ovariectomized ewes [9]. 
The KNDy network and GnIH neurons have also been implicated in steroid hormone feedback 
onto GnRH neurons. In females, tonic negative feedback effects of estrogen and progesterone prevail 
throughout most of the ovarian cycle. In the late follicular phase of the cycle, a neuroendocrine switch 
occurs, and a transient, estrogen-induced positive feedback effect causes the preovulatory surge in 
GnRH/LH [265]. The surge in LH secretion causes ovulation. Because GnRH neurons do not possess the 
requisite sex steroid receptors [7,266,267], feedback signals to these neurons rely on transmission through 
other steroid-receptive cells within the brain. The majority of KNDy neurons express ERα and 
progesterone receptors (PR) [27,31,159,268,269]. The level of expression of kisspeptin, DYN, and NKB 
neuropeptides are all-responsive to gonadal steroid levels [26,28,31,270-275]. Similarly, the GnIH 
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expressing cells also express gonadal hormone receptors, respond to estrogen levels, and have GnRH-
contacting projections [34,122,125,276-278]. 
Although there is evidence that the KNDy network and GnIH are conserved across species, to 
date, there has been no investigation of these cell groups in the economically relevant adult bovine. Thus 
the primary goal of this work was to determine the distribution of kisspeptin, dynorphin, and GnIH in the 
hypothalami of bovine during either the periestrus or diestrus stage of the estrous cycle. In addition, we 
examined the connectivity of kisspeptin and GnIH fibers onto GnRH soma in both periestrus and diestrus 
animals. 
4.3 MATERIAL AND METHODS 
4.3.1 Ethics Statement 
The University of Tennessee Animal Care and Use Committee approved all animal procedures. 
4.3.2 Animals 
Six adult (2 to 4 years old), second parity non-lactating Holstein cows were maintained in an 
open free stall barn with free access to water and fed a total mixed ration once daily. To synchronize the 
estrous cycles, bovine at random stages of their estrous cycle were given an initial dose of GnRH 
(Cystorelin, Merial; 2 ml; 50 µg/ml; IM) and fitted with a progesterone-releasing intravaginal device 
(Eazi-Breed CIDR, Zoetis; 1.38 g progesterone) that was left in place for 7 days. On day 7, the 
intravaginal device was removed and cows were given synthetic prostaglandin cloprostenol (Estrumate, 
Merck Animal Health; 2 ml; 250 µg/ml; IM) to induce luteolysis. Three days after the first dose of 
cloprostenol, all animals were given a second dose of GnRH (Cystorelin; 2 ml; 50 µg/ml; IM). Six days 
after the second dose of GnRH, uteri and ovaries were examined by transrectal palpation and 
ultrasonography (MyLab Five VET, Esaote; 5 mHz linear rectal probe) to confirm the presence of a 
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corpus luteum and an antral follicle. All six animals were randomly assigned to one of two groups: a 
diestrus group (DE, n = 3) and a periestrus group (PE, n = 3). Twenty four hours after transrectal 
ultrasound examination, those selected as part of the PE group were given a second dose of cloprostenol 
(Estrumate; 2 ml; 250 µg/ml; IM) to elicit luteolysis. [279]. In the bovine, periestrus is a period of the 
estrus cycle encompassing –3 days to +4 days from estrus [279,280]. Estrus behavior and LH hormone 
levels were not determined; therefore, this period was defined as a non-progesterone dominated phase of 
the bovine estrous cycle.  
Euthanasia and sample collection were carried out 24 h after transrectal examination for animals 
in the DE group and 24 h after the second dose of cloprostenol for animals in the PE group. Before 
termination, blood samples were taken by jugular venipuncture, and harvested serum was stored at −20°C 
until assayed using the estradiol (ImmunChem Double antibody, MP Biomedicals) and progesterone 
Coat-A-Count Kit (Siemens Medical Solutions Diagnostics). Both assays have been previously validated 
in the bovine [281,282]. Bovine were euthanized and hypothalami collected and fixed as previously 
described [283]. Briefly, animals were given 50,000 IU heparin (Sigma) i.v. and euthanized with an i.v. 
dose of sodium pentobarbital (20 mg/kg) 15 min later. After decapitation, the carotid arteries were 
catheterized, basilar arteries clamped off, and heads perfused with 6 liters of 4% paraformaldehyde in 0.1 
M phosphate-buffered saline, with 0.1% sodium nitrite, pH 7.4. Hypothalamic blocks were dissected with 
the following margins: rostrally–rostral border of the optic chiasm; caudally–rostral to the mammillary 
bodies; laterally–1 cm off midline, lateral to the optic chiasm; and dorsally–0.5 cm above the third 
ventricle. Tissue was stored in 4% paraformaldehyde at 4°C overnight and then placed in 30% sucrose at 
4°C until infiltration was complete. Thick (50 μm) frozen coronal sections were cut in series of six and 
stored at −20°C in a cryopreservative solution until being processed immunohistochemically [284]. 
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4.3.3 Immunohistochemistry 
Neuropeptides were detected using a modified avidin-biotin-immunoperoxidase protocol with 
3,3′-diaminobenzidine as chromogen (brown reaction product). The immunohistochemistry procedure 
was carried out on free-floating sections at room temperature, except for incubation with primary 
antibodies, which were performed at 4°C, as previously described [17]. Briefly, sections were repeatedly 
washed in 0.1 M phosphate buffer with 0.9% saline (PBS) to remove cryoprotectant. Sections used for the 
detection of kisspeptin were subjected to high-temperature antigen retrieval as previously described [267]. 
After washing, the sections were placed in a 1% hydrogen peroxide (Sigma) solution for 10 min to 
remove endogenous peroxidase activity for chromogen detection. The sections were then washed and 
incubated for 1 h in PBS containing 4% normal donkey serum (Jackson Laboratories) and 0.4% Triton X-
100 (Sigma; PBSTX). Alternate sections were then incubated with polyclonal antibodies against GnRH 
(rabbit host; 1:10,000; PA1-121; ThermoFisher Scientific), kisspeptin (rabbit host; 1:30,000; generously 
provided by Alain Caraty, Institut National de la Recherche Agronomique), RFRP-1/3 (rabbit host; clone 
GA197; 1:30,000; generously provided by Greg Anderson, University of Otago School of Medical 
Sciences), or DYN A 1–17 (rabbit host; 1:20,000; IHC 8730; Peninsula Laboratories) for 48 h in PBTX. 
Following incubation, chromogen sections were washed and then placed in a solution of PBSTX with 
biotinylated donkey anti-rabbit IgG (1:1000; Jackson Laboratories) for 1 h. The sections were washed and 
incubated for 1 h in avidin-biotin-HRP complex (1:1000; Vector Laboratories). Neuropeptides were 
visualized using 3,3′-diaminobenzidine and 0.003% hydrogen peroxide as substrate. Control sections for 
the immunohistochemistry procedure included omission of each of the primary antibodies from the 
immunostaining protocol, which resulted in a complete absence of staining for the corresponding antigen. 
In addition, pre-absorption controls were performed for each of the antibodies. In each case, pre-
incubation of the diluted antiserum with nanomolar concentrations of purified antigen (Phoenix 
Pharmaceuticals) was shown to be sufficient to eliminate all specific staining in bovine hypothalamic 
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sections. It should be noted that the rabbit anti-RFRP1/3 clone was generated from the precursor peptide, 
which produces both RFRP-1 and 3 (GnIH) [285]; therefore, labeling the precursor effectively defines 
RFRP-1/3-expressing neurons [112]. The dynorphin A 1–17 antibody shows cross-reactivity with 
dynorphin A 1–13 and none with other prodynorphin derivatives such as dynorphin A 1–8, α-neo-
endorphin, leu-enkephalin, and dynorphin B [204]. The kisspeptin antibody was made from the peptide 
YNWNSFGLRY-NH2 (kp10), corresponding to amino acid residues 43–52 of mouse metastin. This 
sequence has high homology to the predicted bovine protein (GenBank accession number AB466319.1). 
4.3.4 Dual-labeled Immunofluorescence  
To investigate the possible interaction between GnRH-expressing cells and cells immunoreactive 
for GnIH-1/3 or kisspeptin, dual-immunofluorescence was performed. As stated above, sections were 
washed and incubated with the monoclonal antibody mouse anti-GnRH (1:3000; SMI 41, Biolegend) and 
either rabbit antibody GnIH-1/3 (1:10,000) or kisspeptin (1:10,000) for 48 h in PBTX at 4°C. After 
primary incubations, sections were washed and incubated in Alexa Fluor 488 or Cy3 conjugated to 
donkey anti-rabbit or mouse IgG, respective to primary host. Sections processed to detect GnRH and 
kisspeptin were put through antigen retrieval as described above. Omission of one or both of the primary 
antibodies completely removed all corresponding staining.  
4.3.5 Tissue Analysis 
Distribution of immunoreactive cells and fibers was examined in a series of every sixth section 
(50 µm thick each) through the preoptic area and hypothalamus of each animal. Images of labeled 
material were captured using a digital camera (QImaging Retiga 2000R) attached to a Nikon microscope 
(Eclipse E800M), and NIS-Elements software version 4.11 (Nikon). Images were imported into Adobe 
Photoshop CS6 (Adobe Systems) and were not altered in any way except for minor adjustments of 
brightness and contrast. The number of cells identified by immunohistochemistry for a nucleus/region 
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was estimated by summing the total number of cells observed within the borders of each nuclei/region in 
three representative sections from each animal. Areas were identified by examining cresyl violet-stained 
tissue of alternate serial cut sections, under bright-field microscopy.  
GnRH fiber densities and intensity were evaluated by drawing a 250-μm2 square around the 
median eminence. The total area analyzed did not differ between animals. Thresholds were established so 
that labeled fibers in focus were above threshold. The fiber density value (measured in arbitrary density 
units – ADU) consisted of the area (in pixels) covered by labeled fibers divided by total area (in pixels) 
within the boundaries (Nikon Elements). The percentage of GnRH immunoreactive cells with close 
apposition with kisspeptin or RFRP 1/3-ir processes were calculated. Each identified GnRH-ir soma was 
examined under a Nikon A1 confocal with an Eclipse TE2000-E microscope under a 40× objective. 
Digital images were acquired using the NIS Elements AR software. If there were no discernable pixels 
between GnRH-positive cell bodies and GnIH or kisspeptin fibers, the cell was considered to be in close 
apposition to the fiber. All image acquisition and analyses were performed blind to hormone status of 
animal. 
4.3.6 Statistical Analysis 
Results are reported as mean ± SEM. Data were analyzed using the unpaired Student t test, and 
non-normally distributed data points were analyzed using the Mann-Whitney-Wilcoxon test (SAS 
software 9.3; SAS Institute Inc.). Significance was assumed when the probability of values differing by 
chance alone was 0.05 or less. 
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4.4 RESULTS 
4.4.1 Hormone Levels and Ovarian Structures 
Progesterone concentration at the time of euthanasia in the DE group was higher (luteal phase) 
than in the PE group (non-luteal phase; P = 0.03, Figure 4.1). All PE animals had progesterone levels 
below 1 ng/ml. There was no difference in estradiol concentration at the time of euthanasia between 
animals in the DE and PE groups (P = 0.94, Figure 4.1). All animals were found to have a corpus luteum 
and a follicle > 10 mm in diameter at the time of transrectal ultrasound examination performed six days 
after the second dose of GnRH (24 hours before cloprostenol administration). 
4.4.2 Distribution of GnRH Immunoreactivity (-ir) in the PE and DE Bovine 
GnRH-ir soma were distributed throughout the bovine POA and mediobasal hypothalamus 
(MBH). Rostrally, GnRH-ir cells were identified in the diagonal band of Broca (dbB) and the medial 
POA (mPOA; Figure 4.2A–E). They were also found concentrated along the midline in areas of the 
organum vasculosum of the lamina terminalis (OVLT), with a few cells identified in the medial septum. 
Perikarya were also found, to a lesser degree, in the ventral anterior hypothalamic area (AHA) and MBH. 
The number of GnRH neurons varied among regions; however, the majority of GnRH neurons were 
found in the POA. GnRH-ir fibers were identified throughout the bovine hypothalamus, with a high 
density of fibers found along the dbB, in and around the mPOA, lateral hypothalamus, OVLT, 
surrounding the bed nucleus of the stria terminalis, AHA, and lateral septum. Fibers were also present in 
the ventrolateral AHA and along the ventral-lateral borders of the third ventricle. The largest density of 
GnRH-ir fibers was identified in the MBH directed toward the external zone of the median eminence and 
into the infundibular stalk and pars tuberalis (Figure 4.2 G–H). GnRH-ir cells and fibers were analyzed in 
the hypothalamus and median eminence (ME) of animals in DE and PE. No difference was found in the 
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number of GnRH-ir cells (Figure 4.2F, P = 0.57) in the POA. Nor was there a measurable difference in 
the degree of ADUs above threshold (Figure 4.2 J, P=0.15) and area of GnRH-ir fibers in the ME (Figure 
2K, P = 0.051) between animals in the DE and PE groups. GnRH-ir cell number and fiber area and 
density had similar distribution and level regardless of progesterone concentration in bovine. 
4.4.3 Distribution of Kisspeptin Immunoreactivity in the PE and DE Bovine 
Kisspeptin-ir was examined in the hypothalamus of six bovines (Figure 4.3A–C). Examination of 
serial sections revealed large clusters of kisspeptin-ir soma in the ARC. A few scattered kisspeptin-ir cells 
were also localized to the preoptic periventricular zone of the hypothalamus adjacent to the third 
ventricle. However, the exiguous number of kisspeptin-ir cells was present in only two of the animals 
(one in the DE group and one in the PE group); therefore, analysis of these cell populations was not 
performed. Kisspeptin-ir cells appeared to be at the highest density in the ARC. Immunoreactive cells 
were distributed throughout the rostrocaudal extent of the ARC. A dense network of kisspeptin-ir varicose 
fibers surrounded kisspeptin-ir soma in the ARC. Cells reached from the ARC into the ventromedial 
nucleus (VMN; Figure43.3A–C). Immunoreactive fibers were also identified in the dbB, OVLT, lateral 
hypothalamus, lateral septum, paraventricular nucleus of the hypothalamus (PVN), and surrounding the 
bed nucleus of the stria terminalis (BNST). Kisspeptin-ir cell number was analyzed in the ARC of DE and 
PE cattle. The number of kisspeptin-ir cells was higher in the PE group compared to the DE group (P = 
0.04, Figure 4.3F). 
4.4.4 Distribution of Dynorphin Immunoreactivity (-ir) in the PE and DE Bovine 
Dynorphin-ir was seen in two morphologically distinct types of cells: magnocellular neurons 
(mean somal diameter = 23.6 ± 3.8 μm) seen in the PVN and supraoptic nucleus (SON); and parvicellular 
neurons (mean somal diameter = 11.2 ± 2.7 μm) seen in the BNST, lateral hypothalamus, dorsomedial 
nucleus of the hypothalamus (DMH), and ARC (Figure 4.4). Dynorphin-ir in the BNST was found in a 
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limited population directly lateral and dorsal to the anterior commissure. Dynorphin-ir fiber labeling was 
also seen in the BNST, predominantly in the portion of this nucleus directly medial to the anterior 
commissure.  
Dynorphin-ir cells were located throughout the rostral-caudal extent of the ARC, with most of the 
cells localized to the dorsal regions (Figure 4.4B–F). The number of dynorphin-ir cells in the ARC 
nucleus was higher in the DE group compared to the PE group (38.0 ± 0.1 and 11.6 ± 7, respectively, P = 
0.001; Figure 4.4G). There was no difference between the DE and PE groups in the number of dynorphin-
ir cells in the DMH (73 ± 4.9 vs. 70.3 ± 8.7; P = 0.80) or the PVN (106.7 ± 10.0 vs. 91.0 ± 16.2; P = 
0.45;Figure 4.4H–I). Higher numbers of dynorphin-ir cells in the ARC nucleus were associated with high 
progesterone levels in cattle. 
4.4.5 Distribution of GnIH-1/3 Immunoreactivity (-ir) in the PE and DE Bovine 
GnIH-1/3-ir cell bodies were observed only within the dorsomedial hypothalamus and distributed 
dorsally into the ventral and lateral borders of the PVN (Figure 4.5A–D). The cells were scattered 
throughout this region and exhibited a neuronal, multipolar morphology. The distribution and number of 
RFRP-1/3-ir neurons were not different between DE and PE female animals (84.3 ± 9.5 vs. 71.3 ± 13.9, 
respectively; Figure 4.5E; P = 0.48). Scattered fibers were detected in the horizontal and vertical limbs of 
the dbB, lateral septum, POA (including the region around the OVLT), periventricular nucleus (PrVN), 
AHA, and rostral aspects of the lateral hypothalamus. In the medial hypothalamus, fibers were observed 
only in the DMH and ventromedial hypothalamus. Only a very few fibers were seen in the ARC and ME. 
  
54 
 
4.4.6 GnRH Connectivity with Kisspeptin or GnIH-1/3 Fibers in the PE and DE 
Bovine  
Kisspeptin-ir fibers and GnRH-ir neuron contacts were identified in the dbB, mPOA, and MBH 
(Figure 4.6A–B). The percent of GnRH-ir neurons with kisspeptin-ir fiber contacts did not vary for each 
region. There was no identified difference in the percentage of GnRH neurons with kisspeptin contacts 
between DE and PE animals (48.7 ± 11.3 vs. 52.3 ± 6.2, respectively; Figure 4.6E). The total mean 
percentage of GnRH-ir neurons in close apposition with kisspeptin-ir fibers was 49.8%. 
Both GnIH-ir fiber and GnRH-ir neuron contacts were identified in the dbB, mPOA, and MBH 
(Figure 4.6C–D). The percent of GnRH-ir neurons with GnIH-ir fiber contacts did not vary by brain 
region and there was no identifiable difference in the percentage of GnRH neurons with GnIH contacts 
between DE and PE animals (30.4 ± 5.2 vs. 35.1 ± 4.2, respectively; Figure 4.6F). The total mean 
percentage of GnRH-ir neurons in close apposition with GnIH fibers was 31.3%. 
4.5 DISCUSSION  
With regard to the changing patterns of GnRH/LH release during the ovarian cycle and due to the 
excitatory effect of kisspeptin and inhibition by GnIH and DYN, we hypothesized that changes in the 
immunoreactivity of neuropeptides of the KNDy cells of the ARC and GnIH, primarily in the DMN, 
would correlate to hormone changes related to the bovine ovarian cycle.  
Bovine GnRH-ir somal and fiber distribution were similar to previous reports, with a majority of 
GnRH neurons found in the mPOA adjacent to the OVLT [286,287]. These cells formed a continuum 
rostrally with immunoreactive neurons in the dbB and medial septum, and caudally with cells in the 
ventrolateral anterior hypothalamus and lateral hypothalamus. Relatively, few cells were seen in the 
anterior hypothalamic area and medial basal hypothalamus. There was no discernable difference in the 
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mean number of GnRH-ir cells between the PE and DE groups. A previous report on GnRH mRNA 
expression in the heifer stated that mid-luteal animals displayed a reduction in the number GnRH mRNA-
expressing cells and number of grains per cell when compared to ovariectomized animals [288]. These 
findings were most likely due to the extreme differences in gonadal hormones when comparing intact and 
ovariectomized animals, which was not endemic of the current study.  
Similar to previous reports, bovine GnRH fibers were mainly found in two major pathways: a 
ventrolateral projection above the optic tract in the anterior and lateral hypothalamus and a less prominent 
periventricular pathway along the third ventricle [286,287]. Differences in GnRH-ir fiber density in the 
median eminence were not identified in PE and DE animals. These findings are not surprising since the 
only previous reports of differences were found in narrow windows comparing animals just before and 
after the GnRH surge; some groups reported increased median eminence GnRH-ir during proestrus 
[289,290] and others a decrease [291,292]. In the monkey, maximum concentration of GnRH fibers were 
identified during the early and middle follicular phases, with a decrease seen during the late follicular and 
ovulatory phases and an increase during the luteal and early follicular phases [293]. In the median 
eminence of the sheep, there is a decrease in GnRH-ir 24 h after ovulation [294]. Samples were not taken 
during this time in the current study to observe the predicted drop after the preovulatory surge. 
As recently reported in juvenile and non-luteal bovine kisspeptin-ir cells were primarily found in 
the ARC, with an elongated distribution from the lateral edges of the ME ventrally to infiltrating the 
borders of the ventromedial nucleus, dorsally [295,296]. As with other species, the majority of cells were 
found in the middle and caudal regions of the ARC. As stated previously, there were little to no 
kisspeptin-ir cells in the POA of the bovine. In rodents, KISS 1 mRNA-expressing cells are located in the 
ARC and the POA [246,297]. In sheep, goats, and deer, the majority of kisspeptin-ir has been reported in 
the ARC, with a smaller cell group in the POA [16,26,27,159].  The present findings suggest the bovine 
expression of kisspeptin is more closely aligned with sheep, humans, and non-human primates, whereby 
56 
 
kisspeptin-ir and KISS 1 mRNA-expressing cells are primarily localized to the ARC [29,270], which is an 
area thought to be important for both positive and negative regulation of GnRH in these species [298,299] 
[300]. 
Our data suggests that progesterone alone or progesterone with an unchanging level of estradiol 
can decrease kisspeptin levels in the ARC of the bovine. The location of kisspeptin-ir cells in the bovine 
ARC is ideally placed to act as the interneuronal link connecting levels of sex steroids to GnRH feedback 
regulation. Kisspeptin expression and immunoreactivity have repeatedly been shown to be altered by 
gonadal steroid fluctuations. Most of kisspeptin cells contain gonadal hormone receptors and are 
responsive to changes in steroid levels [27,31,159,166,268,269,301-304]. In the rat, ARC KiSS-1 mRNA 
expression is highest at diestrus and lowest at proestrus and is increased by ovariectomy and decreased by 
estrogen treatment [302,303]. Importantly, kisspeptin/GPR54 signaling, presumably in the POA, is 
essential for the LH surge in mice [301]. In sheep, a clear species difference is apparent: the MBH region 
of the brain, not the POA, is critical for the acute positive feedback effects of estradiol on GnRH secretion 
[305,306]. The same may be true in the bovine. Like in the cow, ARC kisspeptin-ir neurons in the goat, 
sheep, and doe are more abundant during the follicular phase (low progesterone) compared to the luteal 
phase (high progesterone) [26,28,307]. Similarly, the mean number of kisspeptin-ir cells in the doe ARC 
was similar during the luteal phase and anestrus, suggesting kisspeptin expression in the luteal animals 
was already depressed [308]. Likewise, after P4 treatment of ovariectomized animals, and as progesterone 
levels rise during pregnancy, cells expressing KISS 1 mRNA in the sheep ARC decrease [27,309]. The 
present results indicate that distribution of kisspeptin-ir cells and changes across the estrous cycle in the 
female bovine are similar to that in the ewe, doe, goat, and female rhesus monkey.  
It has been shown that kisspeptin neurons are located upstream of GnRH neurons to stimulate LH 
release [310].  Because the excitatory effect of kisspeptin on gonadotropin secretion is inhibited by GnRH 
antagonists [235], and as kisspeptin administration to hypothalamo-pituitary disconnected ewe models 
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could not change LH concentration [172], it has been concluded that kisspeptin acts at the hypothalamic 
level, not the pituitary, to stimulate GnRH release. Kisspeptin-ir contacts have been observed on GnRH 
cell bodies and dendrites in mice [246,249], sheep [11], horses [247,248], monkeys [29], and humans 
[184]. In sheep, these contacts co-localize with synaptophysin, providing further evidence of functioning 
synaptic terminals [245]. Along with fiber-somal connections, kisspeptin-ir fibers contact GnRH fibers in 
the ME of the mouse [311] and goat [214]. GnRH fibers in the ME have often been implicated in control 
of GnRH pulsatile release [173,219,312,313].  The presence of kisspeptin-ir fibers in the ME, alongside 
GnRH-ir positive fibers, suggests similar regulation is occurring in the bovine.  
Previous studies on the distribution of DYN-ir perikarya and fibers have been carried out in the 
rat [314-317], hamster [318], sheep [319-322], non-human primate [323,324], and human [325]. 
However, while relative DYN protein levels have been reported in the bovine [326,327], there have been 
no studies of the distribution of DYN-ir in the bovine hypothalamus. The present findings are in close 
agreement with earlier studies on the distribution of DYN-ir cells and fibers in the POA and 
hypothalamus of other mammals with large magnocellular DYN cells in the PVN and SON; parvocellular 
cells in the ARC and PrVN; and large fibers densely located in the ARC, PrVN, PVN, and in a circular 
arrangement in the ventral region of the AHA. Of note, there were fewer DYN-ir cells in the POA and 
more intense immunoreactivity in the PrVN than reported in the ewe [319]. The highest degree of 
parvocellular immunoreactivity was seen in the ARC, particularly the middle and caudal regions. There 
were no differences found in the number of DYN-ir cells in the SON, PVN, or PrVN between PE and DE 
animals. In the ARC, there was an increased number of DYN-ir cells in the DE animals. DYN-ir cells in 
the ovine ARC express PR [17] and ovariectomy decreases preprodynorphin mRNA expression in this 
nucleus [272]. In this regard, there is strong evidence that DYN participates in progesterone-negative 
feedback in both pregnant rats [328] and luteal-phase ewes [240]. DYN inhibits episodic LH secretion in 
rats, goats, and sheep [16,206,328].  It is not known whether the same is true in the bovine, but our 
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current findings suggest that bovine ARC DYN cells are responsive to progesterone levels and could be 
playing a part in the gonadal negative feedback on the KNDy “pulse generator” and subsequent GnRH 
release.  In addition to DYN’s role in reproduction, it is functionally involved in a variety of 
neuroendocrine systems, including those mediating feeding [329], water homeostasis [330], lactation 
[331], and the stress response [332]. Therefore, it is important to have a description of the hypothalamic 
distribution of this neuropeptide. 
Bovine GnIH cells were located mainly in the DMN, but also distributed into the PVN and PrVN. 
The distribution of GnIH in the bovine hypothalamus matched well with descriptions of GnIH 
distribution in the mouse [108], goat [307,333], sheep [9,11], rat [112,285], sparrow [150], hamster [121], 
o’possum [334], and primate [335].  The number of GnIH-ir cells was not different between PE and DE 
animals. The lack of change in GnIH-ir in the bovine was not surprising considering previous studies 
have reported conflicting findings. Expression of GnIH mRNA in mice DMN is inhibited by E2 [276] but 
was not found to be different in diestrus, ovariectomized, or ovariectomized plus E2 rats [277]. More 
recently, Salehi et al reported the expression of GnIH mRNA was elevated in diestrus rats when 
compared to proestrus animals [333]. In contrast, female non-human primates display lower neuropeptide 
VF precursor mRNA (the gene for GnIH in the primate) expression during the luteal phase than in the 
follicular phase of the menstrual cycle, and in ewes, the expression is reduced during the preovulatory 
period [10,336]. A recent report in the goat identified a greater number GNIH-ir cells in the DMN during 
the luteal stage compared to the follicular stage [307]. The most profound and reproduced changes in 
GnIH protein levels in the DMN have been in comparison of breeding and nonbreeding animals 
[11,334,337]. Perhaps somewhat unique to previous reports, the current findings compared animals with 
equivalent estrogen levels and dissimilar progesterone levels. While not equivalent, in studies where 
GnIH expression was measured in pregnant animals and progesterone levels were elevated, the relative 
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expression of GnIH mRNA in DMN did not change [309]; suggesting changes in progesterone do not 
alter GNIH expression.  
Despite the lack of differences in protein regulation, gonadal steroids may alter GnIH activity. In 
some rodent species and in sheep, a subset of GnIH neurons express estrogen receptors (ERs), but the 
expression pattern in each species is different. In mice, a very small proportion (19%) of GnIH neurons 
express ERα [276], whereas, 40% of GnIH neurons contain ERα in female hamsters  [109]. During 
proestrus in hamsters, c-Fos-positive GnIH neurons are reduced and a subcutaneous injection of E2 
increased c-Fos labeling in GnIH neurons [125]. Although GnIH has been shown to have an effect on LH 
secretion in male calves [13], it is unclear whether GnIH plays a role in the down regulation of GnRH or 
LH secretion in the cycling bovine. Gonadal regulation of GnIH neurons may be species- and 
reproductive stage-dependent.  
GnIH fibers were distributed throughout the POA and MBH. Fibers were identified in the PrVN 
and ARC, which match areas with c-Fos expression after central infusion of GNIH in the mouse [285]. 
Very few fibers were visualized in the external zone of the ME. Although GnIH fibers have been 
identified in the ME of hamsters [109,125] and sheep [9,35], rat [108,109,112,285], non-human primates 
[34,336], and o’possums [334], the amount and distribution into the external zone varies greatly between 
species [34,334,336]. In the bovine, few GnIH-ir fibers were localized in the ME, including the external 
zone; thus, we could predict a limited hypophysiotropic role for GnIH in the bovine. However, GnIH has 
been shown to inhibit LH release in castrated male calves and cultured anterior pituitary cells of cattle 
[13].  This suggests the molecular mechanisms are present for GnIH inhibition of GnRH-induced LH 
release from bovine gonadotropes. It remains to be determined if such mechanisms are involved in the 
regulation of LH in cycling females. Similar findings have been reported in the sheep, a species with 
more GnIH-ir fibers in the external zone of the ME than the bovine. Likewise in the sheep, GnIH has 
been detected in the portal vasculature [118]; however, the levels of portal GnIH levels do not vary 
60 
 
between luteal and follicular ewes, but are elevated in the non-breeding season when reproductive activity 
is suppressed [118]. This suggests an active role for GnIH in the seasonal breeding, but perhaps not 
estrous cyclicity. Additional work is needed to fully characterize the role GnIH plays in bovine 
reproduction, but the current findings suggest the GnIH immunoreactivity in the bovine ME is similar to 
the rodent.  
We report for the first time that roughly 30% of GnRH neurons have GnIH appositions in the 
female bovine, suggesting that a portion of GnRH neurons in this region may respond to GnIH. The GnIH 
terminals appear to make close appositions to GnRH neurons in mice, rats, hamsters, poultry, and sheep 
[34,109-111,260,261,263,278,338-341].  In addition, approximately 15–30% of GnRH neurons express 
mRNA for the GnIH receptor GPR147 in mice [122,259]. There was no difference in the portion of 
GnRH cells with GnIH contacts between DE and PE animals; however, the degree of connectivity 
between GnIH terminals and GnRH is altered in sheep during the breeding season compared to the 
anestrous season [11]. 
The distribution of GnIH fiber projections in widespread brain areas of the bovine and other 
species suggests that GnIH may be involved in a range of physiological functions. Central infusion of 
GnIH elicits increased food intake in birds, rats, and sheep [10,261,342,343].  Centrally or peripherally 
administered GnIH also inhibits sexual behavior [261] and induces anxiety-like behavior [344,345] in 
male rats. Accordingly, an increase in GnIH neurons in the DMN and GnIH fiber projections in the POA 
after antidepressant treatment correlates with sexual dysfunction in male mice [346]. Although the present 
study did not identify a difference in GnIH immunoreactivity or GnRH/GnIH connectivity between PE 
and DE bovines, there is growing evidence that GnIH plays a large role in seasonal anestrus, puberty 
onset, and HPG inhibition associated with satiety in seasonal breeders [11,12,35,145,334,347-349]. 
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In conclusion, it is clear from these results that the neuroanatomical distribution, possible 
synaptic connectivity, and response to altered progesterone levels suggest these neuropeptides play a 
pivotal role in the regulation of the reproductive cycle in cattle. More studies are needed to determine the 
precise role GnIH, kisspeptin, and DYN play in the neuroendocrine control of bovine reproduction. 
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4.6 APPENDIX 
 
Figure 4.1 Serum progesterone (A) and estradiol (B) concentrations at the time of tissue 
collection in diestrus (DE; luteal phase; n=3) and periestrus (PE; non-luteal phase; n=3) animals. Serum 
progesterone concentration was higher in DE animals when compared to PE animals (P=0.03; 
*=statiscally significant). There was no difference in estradiol concentration between groups. 
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Figure 4.2 GnRH-ir in the bovine POA and ME. A;G) Low power images of a representative 
crystal violet stained sections, red box depicting ME area of photomicrographs. B-E) POA Bipolar and 
unipolar GnRH-ir cells in DE (B,D) and PE (C,E) animals. F) Histogram depicting mean number (± 
SEM) of GnRH-ir cells identified in the POA of DE and PE animals. H-I) ME representative images of 
GnRH-ir cells in DE (H) and PE (I) animals.  J-K) Histograms depicting mean (± SEM) arbitrary density 
units (J) and total area (K) of GnRH-ir fibers in the ME of DE and PE animals. 
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 Figure 4.2 Continued 
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 Figure 4.3  Kisspeptin in the bovine arcuate nucleus. A) Low power image of a representative 
crystal violet stained section with red box depicting area of photomicrographs. B-E) Representative 
images of kisspeptin-ir cells in DE (B, D) and PE (C, E) animals. F) Histogram depicting mean number (± 
SEM) of kisspeptin-ir cells identified in DE and PE bovine. (* = statistically significant, p = 0.04).  
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 Figure 4.4 Dynorphin (DYN) in the bovine hypothalamus. A) Low power image of a 
representative crystal violet stained section with red boxes depicting areas of photomicrographs. B-F) 
Representative images of DYN-ir cells in the arcuate nucleus of the diestrus (B) and periestrus (C) 
animals. Representative low (D) and high power (E) images of DYN-ir cells in the dorsomedial nucleus 
and (F) paraventricular nucleus. Histogram depicting the mean number (± SEM) of DYN-ir cells 
identified in the diestrus and proestrus bovine (G) arcuate nucleus, (H) dorsomedial nucleus and (I) 
paraventricular nucleus. (* = statistically significant, p = 0.001). 
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 Figure 4.5 GnIH in the bovine dorsomedial nucleus of the hypothalamus. A) Low power image of 
a representative crystal violet stained section with red box depicting area of photomicrographs. B-D) 
Representative images of GnIH cells in bovine dorsomedial nucleus. E) Histogram depicting mean 
number (± SEM) of GnIH-ir cells identified in the DE and PE bovine dorsomedial nucleus of the 
hypothalamus. 
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 Figure 4.6 Neuropeptide connectivity to GnRH in the bovine hypothalamus. A-D) Representative 
images of GnRH-ir (green) cells with (A, C) or without (B, D) Kp (A-B) or GnIH (C-D) -ir fibers (red) in 
close apposition (white arrows). Histograms depicting mean percent (± SEM) of GnRH-ir soma identified 
to have close apposition with Kp-ir (E) or GnIH-ir (F) in DE and PE animals. 
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CHAPTER 5 
INTRAVENOUS ADMINISTRATION OF GNIH DECREASES BASAL 
RELEASE OF LH BUT HAS NO EFFECT ON SURGE RELEASE OF LH 
IN INTACT POST-PUBERTAL HOLSTEIN HEIFERS 
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5.1 ABSTRACT 
Gonadotropin-inhibitory hormone (GnIH) is a hypothalamic RF-amide-related neuropeptide that 
has been shown to decrease LH concentrations in birds and mammals. However, to date, there are no 
reports of studies that examined the effects of GnIH in heifers. In this study, Experiment 1 tested the 
hypothesis that GnIH would decrease basal LH concentrations during the late follicular phase of the 
estrous cycle in intact post-pubertal Holstein heifers. Treatment with 10 µg/kg GnIH (iv) every 10 min for 
1 h reduced serum LH concentrations over time (treatment, P = 0.02; time, P = 0.73; treatment by time 
interaction, P = 0.19), mean LH concentration (P = 0.01), and area under the curve for the treatment 
period (P = 0.008) when compared to saline-treated controls. A second experiment was designed to 
determine effects of GnIH (10 µg/kg/h iv) administered during the time when the LH surge was expected. 
No differences were seen between GnIH and saline-treated groups with regard to mean plasma LH 
concentrations (P = 0.86), LH surge amplitude (P = 0.35), time to the start of the LH surge (P = 0.73), 
length of the LH surge (P = 0.29), and area under the curve (P = 0.39). Daily transrectal ultrasonography 
revealed no difference in dominant follicle growth over time (treatment, P = 0.15; time, P = 0.06; 
treatment by time interaction, P = 0.62) or maximum follicular diameter (P = 0.64) between the GnIH and 
saline-treated groups. In conclusion, these results suggest that intravenous administration of GnIH at 10 
µg/kg in intact, post-pubertal Holstein heifers reduces basal LH concentrations but has no effect on serum 
LH concentrations associated with the LH surge around the time of estrus nor ovulatory follicle growth 
characteristics. 
5.2 INTRODUCTION 
In mammals, GnRH is the main hypothalamic neuropeptide known to date to regulate 
reproduction. This hormone is secreted into the hypothalamic pituitary portal system in pulses which 
change in frequency and amplitude depending on the stage of the estrous cycle [350]. In the presence of 
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low levels of progesterone, estradiol secreted by the preovulatory follicle has a positive feedback on 
discrete regions of the hypothalamus increasing GnRH pulse frequency, an important first step towards 
eventually eliciting the preovulatory luteinizing hormone (LH) surge [5]. In contrast, when plasma 
progesterone concentrations are high, estradiol secretion form ovarian follicles has a negative feedback 
with the hypothalamus maintaining GnRH pulse frequency low [350]. Although GnRH was discovered in 
the 1970’s [2,3], the mechanisms behind the regulation of its pulsatile secretion remain to be completely 
elucidated.  
Several hypothalamic neuropeptides have been implicated in the regulation of GnRH neurons and 
in turn LH secretion. One of the neuropeptides implicated in the down regulation of reproduction is 
gonadotropin inhibiting hormone, an RF-amide related peptide (GNIH) encoded by the RFRP 1 and 3 
genes [260]. GnIH was first discovered in the quail and was shown to decrease secretion of LH from 
cultured anterior pituitary cells [8]. The mammalian form of GnIH, RFRP-3, was then discovered in 
hamsters and rats as a hypothalamic “negative” regulator of LH secretion [36,351]. Neurons that secrete 
GnIH have been shown to reside in the dorsomedial hypothalamus and paraventricular nucleus of ewes 
[9,11]. In sheep and cattle, these neurons project into the preoptic area of the hypothalamus and have 
close apposition with GnRH cells suggesting a hypothalamic mechanism of action [9,352]. Additionally, 
in situ hybridization and immunohistochemistry studies in ewes have shown that neurons expressing 
GnIH also have projections into the median eminence [9]. This suggests a direct effect of GnIH on the 
pituitary in sheep. In vivo studies support the hypophysiotrophic action of GnIH. Ewes treated with a 
constant rate infusion of GnIH during the late follicular phase had lower plasma LH concentrations 
compared to the saline treated controls [10]. Authors in another study were able to ablate the estradiol 
benzoate induced LH surge in ewes with iv GnIH treatment. Finally studies in ovariectomized ewes 
showed a decrease in basal LH concentrations when GnIH was administered IV at a constant rate infusion 
[9].  
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In addition to sheep, GnIH is hypothesized to have a pituitary effect in male calves [13]. 
Administration of 10 ug/kg of mammalian GnIH over an hour by iv injections every 10 minutes, lowered 
plasma LH concentrations in gonadectomized male calves. However, the effects of GnIH on the 
reproductive axis of intact post-pubertal heifers have not been studied.  
Given the effects of peripheral administration of GnIH in sheep and male calves, we hypothesized 
that intravenous administration of mammalian GnIH would decrease plasma LH concentrations in intact 
post-pubertal Holstein heifers. The objective of the first study was to determine whether IV GnIH 
administration would decrease basal plasma LH concentrations. The second study was designed to 
determine whether continuous administration of GnIH during the expected time of the LH surge has an 
effect on serum LH concentrations, follicular growth and ovulation. 
5.3 MATERIALS AND METHODS 
5.3.1 Experiment 1 
Animals 
Sixteen post-pubertal Holstein heifers between 12 and 24 months of age and weighing between 
340 and 380 kg were utilized for this study according to the animal use protocol approved by the 
University of Tennessee Animal Care and Use Committee. Animals were selected based on sexual 
maturity which was determined to be when at least two of three serum progesterone concentrations 
determined once a week for three consecutive weeks were greater than 1 ng/ml [353]. Animals were 
maintained in an open free stall barn with free access to water and fed a total mixed ration once daily and 
restrained in headlocks during blood sampling.  
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Synchronization 
Heifers at random stages of the estrous cycle were treated with 100 µg of GnRH ( Cystorelin®; 2 
mL; 50 µg/mL im, Merial, Duluth, GA, USA) and a progesterone intravaginal device (Eazi-Breed™ 
CIDR Zoetis, Kalamazoo, MI, USA) was inserted. Five days later intravaginal devices were removed and 
heifers were treated with 500 µg of cloprostenol IM (Estrumate; 2 mL; 250 µg / mL, prostaglandin 
agonist) and their ovaries were examined by trans-rectal palpation and ultrasonography (5 mHz linear 
rectal probe, MyLab Five vet, Esaote, Indianapolis, IN, USA) to assess synchronization efficiency. On the 
same day of cloprostenol treatment, two jugular catheters (14 gauge 9 cm Milacath Extended Use 
Catheter) were inserted in each heifer. Blood samples were collected through one of the catheters and the 
other one was used for treatment injections. Catheters were flushed with heparinized (20 IU / mL) saline 
(0.9% NaCl) (≤ 10 mL) following each blood collection. (Fig.1, a).  
Treatments and blood sampling  
Eight post-pubertal Holstein heifers with a dominant follicle (defined as a follicle >8mm in 
diameter [58,354]) and progesterone below 1 ng/ml after estrus synchronization, were randomly assigned 
to one of two treatment groups. Studies were carried out in two replicates of four animals each for a total 
of four animals per group: a) Control (2 mL per injection, saline, iv) and b) GnIH at 10 µg/kg/h 
(VPNLPQRF-amide, 95% purity in 2 mL saline, iv, EZ-Biolab, Carmel, IN, USA). Selection of the dose 
of GnIH used was based on results from previous experiments in sheep [9,104] and male calves [13]. All 
animals in the GnIH treatment groups were given an initial loading dose of 1 mg/100 kg body weight of 
GnIH. The total dose for the animal was divided into six injections (iv) given ten minutes apart for 1 h 
given that such interval was able to decrease LH pulse frequency in cattle [13]. Intravenous 
administration was chosen based on previous studies carried out in ewes [9,104,129] and male calves [13] 
that suggest a direct effect of GnIH on the gonadotropes of the pituitary. Blood samples were collected 
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every 10 minutes for 5 hours starting 24 hours after cloprostenol treatment (from 2 h before to 2 h after 
experimental treatment Figure 5.1 a) and harvested serum was stored at -20 C until assayed. An initial 
blood sample was obtained to verify progesterone concentrations before experimental treatments began to 
avoid any potential confounding effects of progesterone on LH secretion (progesterone Coat-A-Count Kit 
(Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA) [355]. Frequent blood samples were 
assayed for serum LH concentrations [356]. Bovine LH standards and anti-bovine LH were obtained from 
the National Hormone and Peptide Program (Harbor-UCLA Medical Center, Los Angeles, CA, USA). 
Sensitivity of the assay was 0.03 ng/mL. The intra-assay and inter-assay CVs were 4.13% and 4.07%, 
respectively. 
5.3.2 Experiment 2 
Animals 
Sixteen post-pubertal Holstein heifers between 12 and 24 months of age and weighing between 
320 and 350 kg were used according to the animal use protocol approved by the University of Tennessee 
Animal Care and Use Committee. Animals were selected based on sexual maturity as described for 
experiment 1 [353]. Before experiments began heifers were acclimated to halter restraint to facilitate 
intensive serial blood collection. For acclimation, heifers were fitted with halters and restrained once a 
day at increasing time intervals for two weeks. During these periods, heifers were periodically brushed 
and had continuous access to hay and water with lead ropes long enough to allow them to stand or lie 
down.  
Synchronization 
Heifers at random stages of the estrous cycle were synchronized as described in experiment 1 
(Figure 1 b).  
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Treatment and blood sampling 
Selection of eight heifers from those with estrous cycles synchronized as described previously, 
was based on follicular size examined by trans-rectal ultrasonography at the time of cloprostenol 
treatment. Those animals with a dominant follicle (>8.5 mm in diameter [58,357]) were randomly 
assigned to one of two treatment groups in two replicates of four animals each for a total of four animals 
per group: a) Control (10 mL/h saline, 0.9% NaCl); b) 10 µg/kg/h GnIH (VPNLPQRF-amide, 95% purity, 
EZ-Biolab; CRI at 10 mL/h). All animals in the GnIH treatment group were given an initial loading dose 
of 1 mg/100 kg body weight of GnIH. The total dose needed for the treatment period was diluted in 1L of 
saline (0.9% NaCl) and administered intravenously by CRI through medical grade infusion pumps (9 
mL/hr, Vet/IV Infusion Pump 2.2, Heska, Loveland, CO, USA) for 108 hours starting on the day of 
cloprostenol treatment and catheter placement (Figure 1 b). Intravenous administration was chosen based 
on previous studies carried out in ewes [9,129] and cattle [13] in which IV administration of GnIH 
decreased serum LH concentrations. A constant rate infusion was chosen to address any concerns with the 
half-life of GnIH and to be able to administer treatments for the number of hours needed to ensure that 
animals were being infused during the occurrence of their LH surge [358,359]. Frequent blood sampling 
was initiated 24 hours after starting treatment and carried out every hour for 60 hours. Treatment was 
continued for 24 hours after the last blood sample. Daily blood samples were also collected for 
progesterone measurements to ensure response to synchronization drugs and assayed using progesterone 
Coat-A-Count® Kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA) [355]. Frequent 
blood samples were assayed for serum LH levels by radioimmunoassay as done for experiment 1. Intra-
assay and inter-assay CVs were 17.44% and 13.20%, respectively. Ovaries of heifers were examined by 
trans-rectal palpation and ultrasonography every day once a day until ovulation had occurred or up to 48 
hours after discontinuing treatment to assess follicular dynamics (MyLab Five vet; 5 mHz linear rectal 
probe). 
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5.3.3 Statistical Analysis 
Results are reported as mean ± SEM. An LH pulse was defined as a value 1 SD above the mean 
LH concentration. The beginning of the LH surge was defined as the first value 1 SD above the pre-surge 
LH average. The end of the LH surge was defined as the first value 1 SD below the pre-surge LH average. 
Single-point measurements were compared by two-way ANOVA to determine the effects of treatment 
and replicate. Serial data were compared among groups by two-way ANOVA for repeated measures using 
a mixed procedure in SAS (Statistical Analysis System Institute, Inc., Cary, NC, USA) to determine the 
effects of treatment and replicate over time. In the absence of a replicate effect, data from replicates were 
combined and compared using an unpaired Student t test. In both experiments, significance was assumed 
when P ≤ 0.05. 
5.4 RESULTS 
5.4.1 Experiment 1: Effect of GnIH on basal serum LH concentrations 
Serum progesterone concentrations at the time of treatment were 0.20 +/- 0.03, and 0.29 +/- 0.29 
ng/ml for the saline, and 10 µg/kg GnIH treatment groups respectively (P=0.27; Table 5.1).  Serum LH 
concentrations over time during the treatment period were significantly lower in the 10 ug/kg GnIH group 
when compared to the saline treated group (treatment P=0.02; time P=0.73 and treatment by time 
interaction P=0.19; Figure 5.2 C). There was no difference in the number of pulses (1.25 +/- 0.25 and 1 
+/- 0.0 for the saline and 10 ug/kg GnIH treatment groups respectively; P=0.35; Table 5.1) or the pulse 
amplitude (0.46 +/- 0.16 and 0.49 +/- 0.11 for the saline and 10 µg/kg GnIH treatment groups 
respectively; P=0.72; Table 5.1) during the treatment period between the GnIH and saline treated groups.  
There was a tendency for LH pulse concentration to be lower during the treatment period in the GnIH 
treated group as compared to the saline treated group (1.25 +/- 0.07 and 1.07 +/- 0.05 for the saline and 10 
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µg/kg GnIH treatment groups respectively; P=0.07). The total average LH concentration (0.94 +/- 0.1 and 
0.82 +/- 0.09 for the saline and 10 µg/kg GnIH treatment groups respectively; P=0.01; Table 5.1) and the 
area under the curve (48.7 +/- 1.93 and 39.5 +/- 1.41 for the saline and 10 µg/kg GnIH treatment groups 
respectively; P=0.008; Table 5.1) during the treatment period was lower in the GnIH treated group as 
compared to the saline treated group. 
5.4.2 Experiment 2: Effect of GnIH on serum LH concentrations during the 
estimated time of the LH surge  
There was no difference in serum LH surge concentrations over time between animals in the 
saline and 10 µg/kg GnIH treated groups (treatment P=0.59; time P=0.002; treatment by time interaction 
P=0.69; Figure 5.3). There was no difference in average LH surge concentration (7.41 +/- 2.58 and 7.37 
+/- 3.27 ng/ml for the saline and 10 µg/kg GnIH treatment groups respectively; P=0.86; Table 5.2), LH 
surge amplitude (10.50 +/- 2.95 and 14.34 +/- 1.72 ng/ml for the saline and 10 µg/kg GnIH treatment 
groups respectively; P=0.35; Table 5.2), time to the start of the LH surge (25 +/- 8.39 and 28.66 +/- 3.52 
hours for the saline and 10 µg/kg GnIH treatment groups respectively; P=0.73; Table 5.2), length of the 
LH surge (8.75 +/- 0.62 and 10.33 +/- 1.33 hours for the saline and 10 µg/kg GnIH treatment groups 
respectively; P=0.29; Table 5.2) or the area under the curve of the LH surge (68.8 +/- 7.2 and 81.2 +/- 
10.6 for the saline and 10 µg/kg GnIH treatment groups respectively; P=0.39; Table 5.2) between animals 
in the saline and 10 µg/kg GnIH treatment groups.   
There was no difference in the size of the dominant follicle before experimental treatments began 
(11.78 +/- 0.85 and 11.05 +/- 0.76 mm for the saline and 10 µg/kg treatment groups respectively; P=0.27) 
or the maximum size of the dominant follicle (14.6 +/- 0.64 and 14.8 +/- 1.06 mm for the saline and 10 
µg/kg treatment groups respectively; P=0.64) between animals in the saline and 10 µg/kg GnIH treatment 
groups. Similarly, there also was not difference in the size of the dominant follicle over time between 
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animals in the saline and 10 µg/kg GnIH treated groups (treatment P=0.46; time P=0.02; treatment by 
time interaction P=0.69; Figure 5.4).  
5.5 DISCUSSION 
Gonadotropin inhibiting hormone has been shown to decrease serum LH concentrations in 
various species including male castrated calves [13]. These studies soµght to determine for the first time 
whether mammalian GnIH could suppress serum LH concentrations in intact post-pubertal Holstein 
heifers.  
The first study showed that exogenous IV administration of GnIH was able to decrease serum 
basal LH concentrations over time during the treatment period. This was reflected in a lower mean LH 
concentration and area under the curve for the treatment period in the GnIH treated group. Pulse 
concentration in the GnIH treated group also tended to be lower but there were no differences between 
pulse frequency or number of pulses between the saline and GnIH treated group during the treatment 
period. Given the synchronization protocol used in this experiment, animals were in the late follicular 
phase of the estrus cycle at the time of treatment.  The decrease in serum LH concentrations observed in 
the first experiment during this time of the estrus cycle is consistent with a study carried out in intact ewes 
which reported a decrease in mean levels of plasma LH concentrations during the late follicular phase 
[10]. We did not, however, follow follicular dynamics beyond the treatment period and therefore could 
not determine whether such decrease in basal LH concentrations during the late follicular phase had an 
effect on final follicular growth and ovulation. 
In male castrated calves, the same intravenous dose used in the experiments reported here, 
decreased plasma LH pulse frequency but there was no difference in  total plasma LH concentration or 
pulse amplitude [13]. These differences found across species and animal models reflect the difficulty in 
documenting the decrease in basal levels of pulsatile secretion of LH, but overall, they indicate a 
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suppressing effect of GnIH on LH at the level of the pituitary. GnRH secretion from the hypothalamus 
and in turn secretion of LH from the pituitary is influenced by gonadal steroids. In the absence of such 
regulation, overall LH secretion increases 2-3 fold above what is observed in intact animals [360,361]. 
Therefore the effects of GnIH in gonadectomized models, if small, are more likely to be evident as 
compared to intact animals. Nonetheless, this experiment was able to demonstrate a decrease in overall 
LH concentrations during the treatment period in GnIH treated intact post-pubertal Holstein heifers. 
Basal LH secretion and LH secretion during the LH surge are thought to be differentially 
regulated by the hypothalamus in mammals [362]. In experiment 2 exogenous IV administration of GnIH 
failed to decrease serum LH concentrations during the LH surge. There are confounding results in other 
mammals regarding the effects of GnIH on LH secretion. Similar to results in this study, intravenous 
administration of GnIH in ovariectomized rats only minimally reduced GnRH-stimulated LH release 
[112].  These results differ from previous studies carried out in ovariectomized ewes in which animals 
had a significant decrease in plasm LH concentrations after being treated for 8 hours with an IV infusion 
of GnIH after administration of estradiol benzoate (EB) to induce an LH surge [10]. EB is an estradiol 
analogue that mimics the high levels of steroids secreted by the dominant follicle and can be used to 
induce an LH surge approximately 14-18 hours after administration [358,363]. With the use of EB 
researchers were able to more precisely time the occurrence of the LH surge and treat with GnIH for a 
shorter period of time. It is possible that long term administration of GnIH as done in experiment 2 (total 
of 108 hours) could have prevented GnIH from having an effect on the LH surge. This effect is similar to 
effects of administration of other neuropeptides such as GnRH analogues where LH secretion is 
suppressed when administered long term as opposed to single short term administration where it increases 
LH secretion [364]. Gonadotropes can be directly down-regulated by chronic GnRH administration 
suppressing the naturally occurring effects of GnRH on the pituitary [364]. Since GnIH has a direct effect 
on the pituitary in ewes and male calves, it is possible that such down-regulation also occurs during long 
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term administration of GnIH which in turn would result in comparable LH secretion between the GnIH 
and saline treated group as seen in experiment 2. Therefore it is possible that with long term 
administration, GnIH no longer suppresses LH secretion as opposed to when it is administered at short 
pulse-like intervals like done for experiment 1. Furthermore, in ewes GnIH secretion into the 
hypothalamic-pituitary portal blood system is higher during seasonal anestrus but there is no difference in 
GnIH secretion between the luteal and follicular phase during the breeding season [118]. This may 
suggest that GnIH acts predominantly as an inhibitory neuropeptide setting the negative tone of basal LH 
pulsatility rather than having a role in the surge release of LH in both ewes and cattle. 
During the late follicular phase, LH plays an important role in final maturation of the dominant 
follicle [364,365]. In experiment 2, trans-rectal ultrasonography was used to determine effects of 
treatment on growth of the dominant follicle. No differences were found in the maximum size of the 
dominant follicle or in growth of the dominant follicle over time. Given that there was no decrease in the 
secretion of LH in experiment 2, it is likely that follicles continued to develop normally under the 
influence of LH around the time of the preovulatory LH surge [364,365].  
These experiments were carried out with four animals per group. It is important to consider that 
the number of animals could have prevented the clear identification of small differences in LH 
concentrations and timing of LH surge events. 
In conclusion, results from the present studies suggest that exogenous administration of GnIH 
decreases basal LH concentrations but is not able to suppress the surge release of LH or ovulation in 
intact sexually mature Holstein heifers. Results from these studies also suggest that intravenous 
administration of GnIH has no effect on follicular dynamics in intact sexually mature Holstein heifers. 
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5.6 APPENDIX 
 
Figure 5.1 Schematic summary of synchronization and treatment protocols used for Experiments 
1 (A) and 2 (B). Animals were synchronized using a combination of gonadotropin-releasing hormone, an 
intravaginal progesterone-secreting device (CIDR), and cloprostenol (PGF2α). Animals in Experiment 1 
(A) were treated every 10 min with either 2 mL saline or 10 µg/kg gonadotropin-inhibitory hormone 
(GnIH, iv) for 1 h starting 26 h after cloprostenol treatment. Blood was collected every 10 min for a total 
of 5 h (2 h before to 2 h after the treatment period). Animals in Experiment 2 (B) were treated with a 
constant rate infusion of either saline (10  mL/h iv) or GnIH (10 µg/kg/h iv) starting on the day of 
cloprostenol treatment for a total of 108 h. Frequent blood sampling was done every  hour for 60 h 
starting 24 h after cloprostenol treatment. Transrectal ultrasonography of the ovaries was completed daily 
starting on the day of cloprostenol treatment until ovulation occurred or until 48 h after treatment was 
discontinued. 
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 Figure 5.2: Plasma LH concentrations of intact post-pubertal Holstein heifers during Experiment 
1. Plasma LH concentrations for representative animals treated with gonadotropin-inhibitory hormone 
(GnIH, 10 µg/kg iv, A) or saline iv (2 mL iv, B) every 10 min for 1 h (Experiment 1). (C) Mean plasma 
LH concentrations ( ± SEM) of heifers treated with GnIH (■) or saline (∆) over the treatment period. 
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 Figure 5.3 Serum LH surge concentrations (mean +/- SEM) in intact post-pubertal heifers treated 
with 10µg/kg GnIH () or saline (Δ) during Experiment 2. Individual animals within treatments were 
aligned to their peak LH concentration. 
 
Figure 5.4 Size of the dominant follicle (mean +/- SEM) in intact post-pubertal heifers treated 
with 10µg/kg GnIH () or saline (Δ) during Experiment 2. 
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Table 5.1 Serum progesterone concentration and plasma LH concentration characteristics of 
intact, post-pubertal heifers treated with saline or 10 µg/kg gonadotropin-inhibitory hormone (GnIH) 
during Experiment 1. Different superscript letters indicate differences (P < 0.05) within a row. All values 
(mean ± SEM) are during treatment period unless specified. * On day of treatment. AUC = area under the 
curve. 
 
Saline GnIH – 10µg P-value 
Serum P4 concentration (ng/ml)* 0.20 +/- 0.03 0.29 +/- 0.29 0.27 
No. of pulses (Ave ng/ml + 1SD) 1.25 +/- 0.25 1 +/- 0.0 0.35 
Pulse amplitude (ng/ml) 0.46 +/- 0.16 0.49 +/- 0.11 0.72 
Pulse concentration (ng/ml) 1.25 +/- 0.07a 1.07 +/- 0.05b 0.07 
Average LH (ng/ml) 0.94 +/- 0.1a 0.82 +/- 0.09b 0.01 
AUC 48.7 +/- 1.93a 39.5 +/- 1.41b 0.008 
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Table 5.2: Ovulation and plasma LH surge concentration characteristics of intact, post-pubertal 
heifers treated with saline or 10 µg/kg gonadotropin-inhibitory hormone (GnIH). The start of the LH 
surge was defined as the first value 1 SD above pre-surge plasma LH average concentration. The end of 
the LH surge was defined as the first value below 1 SD of pre-surge plasma LH average concentration. 
AUC= Area under the curve. 
 
Saline GnIH P-Value 
No. animals  with LH surge 4 3 
 
No. animals that ovulated 4 3 
 
Average LH surge concentration 7.41 +/- 2.58 7.37 +/- 3.27 0.86 
LH surge amplitude 10.50 +/- 2.95 14.34 +/- 1.72 0.35 
Time start of txt-LH surge (hr) 25 +/- 8.39 28.66 +/- 3.52 0.73 
Length of LH surge (hrs) 8.75 +/- 0.62 10.33 +/- 1.33 0.29 
AUC of the LH surge 68.8 +/- 7.2 81.2 +/- 10.6 0.39 
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CHAPTER 6 
INTRAVENOUS ADMINISTRATION OF GNIH DOES NOT AFFECT 
SERUM LH CONCENTRATIONS IN OVARIOHYSTERECTOMIZED 
BITCHES 
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6.1 ABSTRACT 
Surgery has been the mainstay of canine sterilization. In recent years there has been a push to find 
a cost efficient, non-surgical, single injection contraception method that could replace surgery. 
Gonadotropin Inhibiting Hormone (GnIH) is a natural occurring hormone secreted from the hypothalamus 
that decreases LH concentrations and potentially ovulation in both birds and mammals. This experiment 
was conducted to study the effects of GnIH in bitches as an alternative to surgical sterilization. Four 
animals were randomly assigned in a cross over design (n=8) to one of two treatment groups: a) Control 
(60 ml/kg/day of saline - 0.9% NaCl IV by constant rate infusion (CRI)); b) 10 µg / kg body weight per 
hour of GnIH-3 (VPNLPQRF-amide, 95% purity; EZ-Biolab; IV CRI at 60 ml/kg/day). Frequent blood 
sampling for LH measurements were taken every hour for 8 hours and treatment was administered for 4 
hours beginning 2 hours after starting treatment. There was no difference in serum LH concentrations 
over time between treatment groups (treatment P=0.93; time P=0.35; treatment by time interaction 
P=0.71; Figure 2). Average LH concentration (56.2 +/- 17.13 and 55.8 +/- 12.6 ng/ml for the saline and 
GnIH group respectively; P=0.94) and the AUC (226.0 +/- 64.24 and 223.9 +/- 44.86 for the saline and 
GnIH group respectively; P=0.98) for the treatment period were not different between animals in the 
saline and GnIH treated groups. In conclusion, this study suggests that intravenous administration of 
GnIH does not decrease serum LH concentrations in ovariohysterectomized bitches. 
6.2 INTRODUCTION 
Overpopulation in US shelters is a rising and emergent problem that leads to the euthanasia of 
thousands of 3.7 million dogs and cats each year [366]. Surgical sterilization (gonadectomies) carried out 
routinely in shelters have decreased numbers of unwanted pets [367,368] but these surgeries have 
significant risk and cost associated with them [369,370]. Furthermore there have been some studies 
suggesting that early removal of gonadal steroids leads to increased risk of other diseases such as cancer 
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later in life [371]. To be able to elucidate more targets for contraception in dogs, it is imperative that we 
better understand the physiological mechanisms behind the control of reproduction in this species. 
Bitches cycle an average of twice a year with long anestrus periods. As in other mammals, GnRH 
in bitches is secreted into the portal system in pulses which change in frequency and amplitude depending 
on the stage of the estrus cycle and is in control of the secretion of gonadotropins from the pituitary [68]. 
GnRH secretion is regulated by ovarian steroids but given that GnRH neurons lack ERα [7], the exact 
mechanisms of action through which ovarian steroids regulate GnRH secretion remains to be fully 
elucidated in dogs. One of the neuropeptides implicated in the down regulation of GnRH and LH 
secretion is gonadotropin inhibiting hormone (GnIH). GnIH is an RF-amide related peptide (RFRP) 
encoded by the RFRP 1 and 3 genes [260]. GnIH was first discovered in the quail to decrease secretion of 
LH from cultured anterior pituitary cells [8]. The mammalian form of GnIH, RFRP-3, was then 
discovered in hamsters and rats as a hypothalamic regulator of GnRH [36,351]. Mammalian GnIH has 
been shown to regulate LH secretion directly from the pituitary in sheep [9,104]. In situ hybridization and 
immunohistochemistry studies in ewes have shown that neurons expressing GnIH have projections into 
the median eminence of the pituitary [9]. The direct effect of GnIH on the pituitary in sheep is supported 
by the results of several studies in which both basal and surge secretion of LH were suppressed when 
GnIH was administered IV at a constant rate infusion [9,10]. In ewes, GnIH is increased during the non-
breeding season (anestrus) as compared to the breeding season [118]. Although not seasonal like sheep, 
bitches also have a long anestrus period in between cycles but the role of GnIH in bitches has not been 
studied. 
For several years there has been an increasing push to discover novel cost efficient, non-surgical, 
single injection sterilizants that can decrease even more the birth of unwanted offspring. Although there 
have been many advances in this area, the final answer still remains elusive. Elucidating the role of 
hypothalamic neuropeptides in small animal reproduction is a step towards discovering novel targets for 
89 
 
such sterilizants. The following experiment was conducted to determine the effects of exogenous 
administration of GnIH on serum LH concentration in ovariohysterectomized bitches. We hypothesized 
that IV administration of GnIH would decrease serum LH concentrations in ovariohysterectomized 
bitches. 
6.3 MATERIALS AND METHODS 
6.3.1 Animals 
Four ovariohysterectomized female hound mix dogs weighing between 16-18 kg and between 7-
10 years old were used in this experiment. Ovariohysterectomies were performed on these animals 
between 5-10 years before this experiment as part of the routine care of research animals at the University 
of Tennessee Small Animal Clinical Sciences department. Ovariohysterectomized bitches were chosen as 
a model for the effects of GnIH on LH as has been done for other species such as the ewe [9]. GnRH 
secretion from the hypothalamus and in turn secretion of LH from the pituitary is influenced by gonadal 
steroids. In the absence of such regulation, overall LH secretion increases 2-3 fold above what is observed 
in intact animals [360,361]. Therefore the effects of GnIH in gonadectomized models, if small, are more 
likely to be evident as compared to intact animals.  This study was carried out in two replicates in a cross 
over design where each animal served as its own control (n=8; 4 animals per treatment group) according 
to the animal use protocol approved by the University of Tennessee Animal Care and Use Committee. 
There was a one week wash out period in between replicates to ensure no carry over effects of the 
experimental drug. During the first replicate, one animal in the saline treatment group, developed 
systemic illness unrelated to the experimental treatments and was euthanized before starting the second 
replicate. Data points from this animal were eliminated from all statistical analyses.   
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6.3.2 Treatments and blood sampling 
For each replicate, animals were sedated and fitted with a 6fr guide wire single lumen jugular 
catheter (MILACATH Mila international INC. Kentucky, USA) for blood sampling. A second catheter 
was placed in a peripheral vein for treatment administration (Teflon over the needle, Mila international 
INC. Kentucky, USA). Animals were randomly assigned to one of two treatment groups: a) Control (60 
ml/kg/day of saline - 0.9% NaCl); b) 10 µg / kg body weight per hour of GnIH-3 (VPNLPQRF-amide, 
95% purity; EZ-Biolab; CRI at 60 ml/kg/day). All animals in the GnIH-3 treatment group were given an 
initial loading dose of 0.01 mg/kg loading dose of GnIH-3. Treatments were started 2 hrs after beginning 
of blood sampling and continued for 4 hours. The total dose needed for the treatment period was diluted 
in 500 ml of saline (0.9% NaCl) and administered IV by CRI through medical grade infusion pumps (ref; 
at 60 ml/kg/day) through the peripheral vein catheter. Blood sampling started 2 hours previous to 
treatment administration for baseline measurements of LH. After 2 hours, CRI treatments began for 
another 4 hours during which sampling also took place every 1 hour. Treatments were discontinued and 
sampling continued every hour for another 2 hours for a total of 8 hours. Frequent blood samples were 
assayed for serum LH levels by RIA (Endocrine lab, Colorado State University, Fort Collins CO). Intra-
assay and inter-assay CVs were 7.20% and 13.0%, respectively. For the second replicate, animals were 
assigned to the opposite treatment in a cross over study design.  
6.3.3 Statistical Analysis 
Results are reported as mean ± SEM. Single-point measurements were compared by paired 
Student’s t-test to determine the effects of treatment and replicate. Serial data were compared among 
groups by two-way ANOVA for repeated measures using the Mixed Procedures of SAS (Statistical 
Analysis System Institute, Inc., Cary, NC, USA) to determine the effects of treatment and replicate over 
time. In the absence of a replicate effect, data from replicates were combined. Tukey's multiple 
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comparison was used as a post-hoc test when a main effect of treatment or a treatment-by-time interaction 
was detected.  Significance was assumed when the probability of values differing by chance alone was 
0.05 or less. 
6.4 RESULTS 
Serum LH concentrations over time for individual animals are depicted in figure 6.1. There was 
no difference in serum LH concentrations over time between animals in the saline and GnIH treated 
groups (treatment P=0.93; time P=0.35; treatment by time interaction P=0.71; Figure 6.2). Average LH 
concentration (56.2 +/- 17.13 and 55.8 +/- 12.6 ng/ml for the saline and GnIH group respectively; P=0.94) 
and the AUC (226.0 +/- 64.24 and 223.9 +/- 44.86 for the saline and GnIH group respectively; P=0.98) 
for the treatment period were not different between animals in the saline and GnIH treated groups. 
6.5 DISCUSSION 
The effects of GnIH in dogs has never been studied despite the potential applications for 
contraception through inhibition of the pre-ovulatory LH surge [9] and potentially, ovulation. In the 
experiments described above, GnIH was administered intravenously to ovariohysterectomized bitches to 
determine the effects on serum LH concentrations. 
Results from this study showed that exogenous administration of GnIH at a dose of 10 μg/kg/hr 
did not have an effect on serum LH concentrations in ovariohysterectomized bitches. Gonadotropin 
inhibiting hormone has been shown to play an important role in anestrus in the cycling ewe [11]. 
Histological examination of sheep brains during the breeding and non-breeding season revealed a 40% 
increase in GnIH cells observed during the non-breeding season [11]. In this same study 
ovariohysterectomized ewes were supplemented with estradiol implants during the breeding and non-
breeding season. Authors reported no difference in GnIH mRNA expressing cells with or without 
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estradiol supplementation. Although non-seasonal, bitches have a long anestrus period in between heat 
cycles and therefore GnIH may also play a role in the regulation of anestrus in this species. The present 
study does not support a role of GnIH in the regulation of LH secretion in bitch when administered at a 
dose of 10 μg/kg/hr. Different from the studies mentioned above in ewes, dogs included in these studies 
were ovariohysterectomized 5-10 years before experiments with GnIH were carried out and with no 
regard to the stage of their estrous cycle. It is possible then, that the chronic exposure to high levels of LH 
[372,373] and lack of cyclic changes in the hypothalamus lead to the infectiveness of exogenous 
administration of GnIH. This is in agreement with studies carried out in Soay ewes in which GnIH gene 
expression difference between induced long and short day photoperiods was lost when animals were 
exposed to extreme long day photoperiod protocols [35]. Although bitches have an anestrus period, this 
time is not regulated by season. Therefore GnIH may not play a role in regulating anestrus but instead, in 
regulating seasonality as it does in ewes [176]. 
GnIH has been found to be secreted in portal blood and GnIH neuron fibers have been shown to 
communicate directly with the median eminence in ewes [9,118]. Intravenous administration of GnIH 
inhibits LH concentrations during the late follicular phase in intact ewes [10] and cattle (Tanco, 
unpublished data). GnIH has also shown to inhibit EB induced LH secretion in ovariohysterectomized 
ewes [10] and plasma LH concentrations in castrated male calves [13]. In these studies, GnIH was 
administered intravenously suggesting a hypophysiotrophic role for GnIH in these species. 
Immunoreactive GnIH terminals have been identified projecting to the median eminence in hamsters, 
sheep and primates supporting a hypophysiotrophic role in these species [9,34,109,121]. Similar 
projections were not found in the rat brain suggesting a predominantly hypothalamic role for GnIH [112]. 
Although some neuropeptides that are thought to have a central rather than a hypophysiotrophic role can 
be administered peripherally to affect reproductive hormone concentrations, it is possible that the lack of 
response to intravenous administration of GnIH in the ovariohysterectomized bitch is due to GnIH not 
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being able to reach its hypothalamic site of action when administered peripherally therefore rendering it 
ineffective at decreasing serum LH concentrations. 
The mammalian sequence of GnIH is encoded by the RFRP gene [374]. The sequence for ewes, 
cattle and humans is the same [9,13,111] but differ from the sequence found in hamsters, mice and non-
human primates [34,109,128]. Nonetheless, the last 3 amino acids of the RF-amide peptides are the ones 
responsible for its biological activity and appear to be highly conserved across species. For example, 
plasma LH levels in sparrows were decreased when treated with the quail form of GnIH [102]. Since the 
exact sequence for the dog has never been studied, it is possible that it differs enough from the bovine and 
sheep sequence used in this study to warrant it ineffective in decreasing serum LH levels in bitches.  
Although GnIH appears to play a role in most species studied, experiments carried out in mares 
failed to show an effect of GnIH on plasma LH concentrations [130]. In cattle, intravenous administration 
of GnIH was able to inhibit basal plasma LH concentrations but had no effect on LH concentrations 
during the preovulatory LH surge (Tanco, unpublished data). These studies suggest that the effects of 
GnIH may be species dependent and mediated through mechanisms different to those observed in birds 
and sheep. 
In conclusion, this study suggests that intravenous administration of GnIH does not decrease 
serum LH concentrations in ovariohysterectomized bitches.  
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6.6 APPENDIX 
 
Figure 6.1 Individual LH concentrations over time of spayed bitches treated IV with a constant 
rate infusion of GnIH (; 10µg/kg) or saline (∆) 
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 Figure 6.2 Average serum LH concentrations over time in spayed bitches treated IV with a 
constant rate infusion of GnIH (; 10µg/kg) or saline (∆) 
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CHAPTER 7 
GENERAL DISCUSSION AND CONCLUSIONS 
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In the attempt to better understand mammalian reproduction mankind has sought after answers to 
basic questions such as the underlying mechanisms of female cyclicity. With the confirmation of the 
existence of GnRH and the discovery of other hypothalamic neuropeptides came the understanding that 
the brain is the mastermind orchestrating not only ovarian activity but also integration of reproduction 
with other internal and external cues. In pursuit of more answers to the specifics of hypothalamic 
neuropeptides and their role in reproduction of different species, we carried out three major studies. 
For our first study we sought to characterize the relative immunoreactivity of GnIH, kisspeptin 
and DYN distribution and their possible connectivity to GnRH neurons in the female bovine brain during 
the stages of low (periestrus) and high (diestrus) progesterone concentrations of the estrus cycle. To this 
end adult female Holstein cattle were euthanized and hypothalami collected either during diestrus or 
periestrus and analyzed using immunohistochemistry for GnRH, GnIH, kisspeptin and DYN. As in 
previous studies [286,287] these experiments found that GnRH immunoreactivity distribution remained 
unchanged in relation to serum progesterone concentrations and estrous status. GnIH immunoreactivity 
also had a similar distribution than previously described and remained unchanged in relation to serum 
progesterone concentrations. This is not surprising given the confounding results in other species 
comparing stages of the estrus cycle and expression of GnIH in the hypothalamus. Projections of GnIH 
fibers to the ME have been reported in the ewe, hamsters and rat, although proportions vary greatly 
among species [34,334,336]. We were only able to see a small number of GnIH projections to the ME in 
the cyclic cow. We report for the first time that roughly 30% of GnRH neurons have GnIH appositions in 
the female bovine hypothalamus although there was no difference in the portion of GnRH cells with 
GnIH contacts between DE and PE animals. These findings taken together suggest a central rather than a 
hypophysiotropic role for GnIH in the bovine. Differences in GnIH expression are more obvious in 
seasonal animals where GnIH protein levels where higher during the non-breeding season [11].The 
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bovine is a non-seasonal breeder and also lacks lengthy anestrus periods therefore it is possible that GnIH 
has an active role in seasonal breeding, but perhaps not estrous cyclicity. 
On the other hand, animals with higher serum progesterone concentrations had lower kisspeptin 
and increased DYN immunoreactivity in the arcuate nucleus. The percentage of GnRH cells with 
kisspeptin fibers in close apposition did not differ between estrous stages. While relative DYN protein 
levels have been reported in the bovine [326,327], there have been no studies of the distribution of DYN-
ir in the bovine hypothalamus. Findings in this study are in line with previous studies in ewes where DYN 
expression was also elevated in the progesterone dominated phase of the estrus cycle suggesting a 
participation in progesterone-negative feedback in luteal phase ewes [240]. Our current findings suggest 
that bovine ARC DYN and kisspeptin cells are responsive to progesterone levels and could be playing a 
part in the gonadal negative feedback on subsequent GnRH release.  
From this first study we conclude that changes in progesterone concentrations during the estrus 
cycle of cattle does not change GnRH or GnIH immunoreactivity and connectivity. We also conclude that 
changes in kisspeptin and DYN immunoreactivity in the ARC of cows suggest a role for these 
neuropeptides in conveying progesterone-negative feedback effects onto GnRH neurons in the bovine 
hypothalamus. This is the first study to report a 30% apposition rate between GnRH and GnIH fibers 
indicating a role of GnIH in GnRH regulation in the hypothalamus and the first to report DYN-ir 
distribution and its relationship to progesterone concentrations in the cyclic bovine. 
To continue exploring the potential effect of GnIH on GnRH and LH concentrations in cattle, we 
designed two more experiments. First we sought to determine if peripheral injections of bovine GnIH 
would have an effect on LH concentrations in intact post-pubertal Holstein heifers. Previous studies 
showed that peripheral administration of GnIH every 10 minutes at a 2.5-10ug/kg doses decreased serum 
LH concentrations in ewes during the late follicular phase and male castrated calves. Using the same 
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model used for calves, we treated intact female Holstein heifers during the late follicular phase with 
10ug/kg of bovine GnIH divided into IV injections every 10 minutes for one hour. We observed lower 
serum LH concentrations during the treatment period in animals treated with GnIH compared to the saline 
treated controls. These results are consistent with those obtained in intact ewes during the late follicular 
phase and suggest a permissive role of GnIH on the secretion of LH leading up to the final maturation of 
the dominant follicle and LH surge.  
Given the results of the first experiment we sought to determine next whether GnIH would have 
an effect on preovulatory concentrations of LH. Intact ewes treated with GnIH after induction of an LH 
surge with EB did not have an LH surge when compared to saline treated controls. As in the study carried 
out in ewes, heifers for our experiment were infused with GnIH for 108 hours during the estimated time 
of the LH surge. We were unable to detect a difference in LH concentrations between GnIH and saline 
treated animals.  Basal LH secretion and LH secretion during the LH surge are thought to be differentially 
regulated by the hypothalamus in mammals [362]. It possible that GnIH in cycling cattle has a differential 
regulatory effect on the tonic GnRH neurons as opposed to those involved in the GnRH/LH surge.  It is 
also possible that due to the limited number of GnIH projections to the ME observed in our 
immunohistochemistry study that GnIH is capable of exerting an overall negative tone on LH secretion 
but that the ME and pituitary do not possess enough number of receptors to allow for GnIH to block the 
massive release of GnRH and LH seen during the preovulatory surge. More studies using localization 
methods for GnIH receptors are warranted. Although GnIH has been shown to inhibit artificially induced 
LH surge in ewes, this is the first report in ruminants of the effects of GnIH in the naturally occurring 
peak release of LH. Lastly, GnIH receptors have been described in theca and granulosa cells of antral 
follicles in pigs and chickens [375,376]. If GnIH was able to decrease LH concentrations during the late 
follicular phase it reasons to assume it would affect the dominant follicle. Daily transrectal 
ultrasonography revealed no difference in follicular diameter or growth of the dominant follicle in GnIH 
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treated animals. It is possible that the frequency of ultrasound examinations were not enough to uncover a 
slight effect and no estrogen measurements were carried out to determine if there was any difference 
between treatment groups. 
From these experiments we conclude that exogenous administration of GnIH decreases basal LH 
secretion but is not able to suppress the surge release of LH in intact post-pubertal Holstein heifers and 
that IV administration of GnIH has no effect on follicular dynamics in intact post-pubertal Holstein 
heifers. These are the only experiments to date that have tested in vivo effects of exogenous GnIH 
administration in the cycling bovine. 
Taken together, it is possible that peripheral administration of GnIH does not have an effect on 
the preovulatory secretion of LH because the main role of GnIH in cattle is at the level of the 
hypothalamus. These results are consistent with those in our immunohistochemistry study in which very 
few terminals were seen at the level of the ME where GnIH is thought to exert its hypophysiotrophic 
effects. Perhaps the small number of GnIH connections at the level of the ME serves to regulate basal 
levels of LH as opposed to the massive release of LH seen during the occurrence of the preovulatory LH 
surge. Similar to our results, in rhesus monkeys, GnIH appositions to GnRH neurons did not change with 
the menstrual cycle [377] and therefore authors suggested that effects of GnIH at the level of GnRH 
neurons was likely not involved in the occurrence of the GnRH/LH surge. It has been hypothesized before 
that GnIH may have more of a permissive rather than an overt inhibitory role on the secretion of GnRH 
especially during the late follicular phase [10]. Moreover GnIH expression was decreased in the 
hypothalamus of rhesus monkeys during the luteal phase most likely indicating that GnIH is not a 
mediator of the inhibitory effects of progesterone on the hypothalamus but rather plays a permissive role 
in the late follicular phase leading up to the pre-ovulatory LH surge. It is also important to keep in mind 
that regulation of GnRH and therefore LH secretion at the hypothalamic level occurs at the tonic and 
surge center of GnRH release. Therefore if GnIH has a predominantly hypothalamic effect it appears from 
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these studies that this effect is at the level of basal LH concentrations regulated by the tonic center in the 
hypothalamus in heifers. 
The role of GnIH may also be more important in seasonal animals or species with long anestrus 
periods where inhibition of reproduction during the non-breeding season becomes more important. To this 
end we tested the effects of peripheral administration in ovariohysterectomized bitches. Although non-
seasonal, this species has an anestrus period that can last between 2-10 months [68,88]. Similar to ewes, 
during anestrus, reproductive hormone levels in bitches are basal. The hormone to reach the highest levels 
during late anestrus is FSH but it is the increase in LH pulsatility 1-2 weeks before the beginning of the 
next heat cycle that elicits the onset of proestrus.  Therefore we hypothesized that GnIH would decrease 
LH concentrations in the bitch. In these studies, we used ovariohysterectomized bitches, as a similar 
animal model used in ewes and to avoid confounding effects of gonadal steroids. Ovariohysterectomized 
bitches were treated IV with GnIH or saline at a constant rate infusion and LH measurements before, 
during and after treatment were compared. GnIH treatment at a dose of 10 μg/kg/hr failed to decrease 
serum LH concentrations in ovariohysterectomized bitches. Although these studied do not support a role 
of GnIH in the regulation of LH secretion, it is important to keep in mind differences in this model as 
compared to the ewe model. For example, bitches for this study had been ovariohysterectomized for over 
5 years. It is possible that the chronic exposure to high levels of LH [372,373] and lack of cyclic changes 
in the hypothalamus lead to the infectiveness of exogenous administration of GnIH. Studies carried out in 
Soay ewes GnIH gene expression difference was lost when animals were exposed to extreme long day 
photoperiod protocols [35]. Since there are no descriptive studies on the distribution of hypothalamic 
neuropeptides in dogs, it is also possible that the mechanism of action for this species does not involve a 
hypophysiotropic component. The lack of an effect of GnIH on serum concentrations of LH in bitches 
could be due to differences in the site of action of GnIH for this species. Although some neuropeptides 
that are thought to have a central rather than a hypophysiotrophic role can be administered peripherally to 
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affect reproductive hormone concentrations, it is possible that the lack of response to intravenous 
administration of GnIH in the ovariohysterectomized bitch is due to GnIH not being able to reach its 
hypothalamic site of action when administered peripherally therefore rendering it ineffective at decreasing 
serum LH concentrations. No studies to date have characterized, if any, the presence or distribution of 
GnIH neurons, peptide or connectivity to other neurons in the canine hypothalamus. Too much is 
unknown of the hypothalamic regulation of reproduction in this species which warrants the further 
investigation of this peptide at the in vitro level before we are able to determine if the lack of effect was 
due to the characteristic of our animal model or the role of GnIH per se in this species. 
We concluded from these results that intravenous administration of GnIH at a dose of 10 μg/kg/hr 
does not decrease serum LH concentrations in ovariohysterectomized bitches. These are the only 
experiments to date that have tested in vivo effects of exogenous GnIH administration in 
ovariohysterectomized bitches. 
The sequence of GnIH used for these studies was compounded by the same laboratory based on 
sequences used in previous studies (VPNLPQRF-amide) and the isolated sequence for bovines [103]. It 
also appears that the last 3 amino acids of GnIH are identical across species and are the ones responsible 
for its biological activity [9,13,128]. Therefore we believe that the source and molecular sequence did not 
affect the results in our in-vivo bovine studies. Although the specific sequence of GnIH for the dog has 
not been isolated, GnIH appears to be a highly conserved molecule among most mammals. It is possible 
though that it differs enough from the bovine and sheep sequence used in this study to warrant it 
ineffective at decreasing serum LH concentrations in bitches.  
Lastly the effects seen in these studies suggest a role for GnIH in the regulation of reproduction. 
Perhaps GnIH instead of having one specific action during the GnRH pulse generating mechanism, it acts 
as an overall negative influence to help set the rhythm of secretion of other hypothalamic neuropeptides 
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and ultimately reproductive hormones.  In conclusion, more studies are needed to determine the precise 
role that GnIH plays in the neuroendocrine control of bovine and canine reproduction. It is clear from 
these studies that the effects of GnIH are species specific and mediated through mechanisms different to 
those observed in birds and sheep. 
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